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 ABSTRACT 
 
Nuclear transfer (NT), or cloning, which is the transfer of a donor nucleus to a 
recipient enucleated oocyte, has been successfully achieved to produce viable 
offspring in many species.  The process is very inefficient, as reprogramming of the 
donor nucleus is required, and losses are high throughout development.  Placentation 
abnormalities are a common feature amongst cloned animals.  Incomplete nuclear 
reprogramming and erroneous epigenetic imprinting may contribute to aberrant 
protein transcription and DNA mutations, affecting mitochondrial metabolism and 
inducing cellular stress.  In vitro produced embryos under high oxygen culture 
conditions may also suffer oxidative stress, with the resulting reactive oxygen species 
causing mitochondrial DNA mutations and cellular stress similar to clones. 
 
In this study, expression of oxidative stress protein markers (Hsp60, SOD2, Hsp70) 
in NT cotyledons were compared to artificial insemination (AI) at different time 
points of gestation (days 50, 100, and 150).  As a continuum of the oxidative stress 
investigation in cloned cotyledons, in vitro produced embryos were cultured under 
20% oxygen compared to the control 7% oxygen laboratory standard culture, with 
oxidative stress protein markers examined between the groups at blastocyst stage (day 
7) and day 15.  Embryo morphology was also observed to determine apparent 
physiological differences between the treatment and control embryos.  No previous 
studies to date have investigated the developmental effects of oxidative stress in day 
15 bovine embryos. 
  ii
The significant differences in oxidative stress proteins observed at several time points 
in the NT and AI groups were not repeatable, possibly due to sample freeze/thaw 
degradation.  Morphological differences observed between embryos cultured in 20% 
oxygen and control groups were visually apparent, although not quantified.  At day 
15 manganese superoxide dismutase expression was significantly lower in the 20% 
group compared to control.  The 20% oxygen group did not show higher heat shock 
protein 60 expression than control, however the same results have been observed in 
another study at blastocyst stage.  The results of this study suggest that the effect of 
oxidative stress on embryonic development is evident yet inconclusive in bovine NT 
cotyledons, however does not appear apparent in day 15 embryos following culture in 
20% oxygen. 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 WHAT IS NUCLEAR TRANSFER? 
 
Nuclear transplantation has long been a topic of interest by man as a means to study 
developmental biology and a method of producing genetically identical animals.  In 
the most basic terms, nuclear transfer (NT) involves transferring the nucleus from one 
cell to another cell which has had its own nucleus removed (Westhusin, 2001).  For 
cloning mammals the NT process involves injecting a donor cell into a mature 
enucleated oocyte.  The donor cell origin may be from embryonic blastomeres, cell 
lines, or primary cultures derived from adult biopsies (Wells, 2005).  An electrical 
stimulus then fuses the donor cell and cytoplast together, followed by artificial 
activation to initiate embryonic development (Wilmut, 2002).   
 
1.1.1 History of Mammalian Nuclear Transfer 
Embryos are grown in vitro to blastocyst stage before transfer to recipient females 
where they may grow into viable cloned animals (Wells, 2005).  The basic NT (or 
nuclear cloning) methodology was developed in the 1950s using amphibians (Wells, 
2003).  The cloning of mammals began in the mid-to-late 1970s with rabbits (Solter, 
2000).  The first successfully cloned live mammal was in sheep using 
undifferentiated embryonic blastomeres (Wells, 2003) and has since been achieved 
using embryonic, foetal or adult cell nuclei in cattle (Forsberg et al., 2002, Kato et 
al., 2000, Oback et al., 2003), goat (Keefer et al., 2002, Reggio et al., 2001), pig 
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(Boquest et al., 2002), rodents (Wakayama and Yanagimachi, 2001b), a cat (Shin et 
al., 2002), rhesus monkey (Meng et al., 1997), rabbits (Chesné et al., 2002), horse 
(Galli et al., 2003), and mule (Woods et al., 2003).  Cloning by NT with somatic cells 
is commonly used to enable rapid multiplication of elite livestock, for various 
agricultural and biomedical purposes, although somatic cell NT cloning of cattle is 
most common due to large numbers of oocytes being available from abattoirs at a low 
cost (Westhusin, 2001). 
 
1.2 WHAT IS A PLACENTOME? 
 
The cow species belongs to a group called “eutherian”, which are those that have 
placentas.  Placenta appearance varies between species.  Bovine embryos have 
specialized cells at the blastocyst stage, trophoblast cells, which form an outer wall 
called the trophectoderm that develops into the placenta (Schafler et al., 2000).  
Based on gross anatomical features, the bovine placenta is classified as cotyledonary 
(Igwebuike, 2005).  This feto-maternal interaction site is distinguished by areas of 
discrete attachment, formed by interaction of patches of the chorioallantois with the 
endometrium in a crypt-villous interrelationship (Igwebuike, 2005, Pfarrer et al., 
2001).  The fetal contribution is called the cotyledon, and the maternal portion of the 
contact site is the caruncle (referred to as the maternal cotyledon).  Together they 
become a placentome (Igwebuike, 2005). 
   3
1.3 PREIMPLANTATION BOVINE EMBRYONIC DEVELOPMENT 
 
Fertilization is the fusion of two specialized cell types, the sperm and oocyte.  
Mammalian oocytes are surrounded by an extracellular coat, the zona pellucida, 
which the sperm binds to upon fertilisation.  The fertilised oocyte becomes a zygote 
where the haploid nuclei of the sperm and oocyte co-exist as separate pronuclei 
before remodelling to form a competent diploid genome.  The two pronuclei fusing 
represent the first cleavage division of the zygote, which takes 32 hours for bovine 
(Rizos et al., 2003).  Cleavage is a series of mitotic divisions without cell growth 
whereby the enormous volume of egg cytoplasm divides into numerous increasingly 
smaller, nucleated cells (Figure 1.1) (Bazer et al., 1987, Latham and Schultz, 2001).  
The second and third cleavages take 13 hours, followed by the fourth cleavage which 
takes 30 hours and is a critical step as it is at this stage that the embryonic genome 
kicks in and often a developmental block occurs (Jansen and Burton, 2004).  During 
cleavage, cytoplasmic volume is not increased and these cleavage-stage cells are 
called blastomeres.  A maternal reservoir of proteins and transcripts in the oocyte 
cytoplasm supports this process and sustains the embryo until compaction when the 
embryonic genome activation occurs (Jansen and Burton, 2004, Wrenzycki et al., 
2005).   
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Figure 1.1  Bovine embryo development to the blastocyst stage. 
ed dots represent nuclei (including pronuclei of zygote), green represents 
lastomeres (also yellow at inner cell mass), and blue represents zona pellucida.  
ime periods in brackets are typical of in vivo development (Source: Professor J 
/lec_18/lec18_images.html#anchor303593). 
t the 8-16 cell stage the bovine embryo undergoes compaction to the morula stage 
here gap and tight junctions are established between the blastomeres to create a seal 
hich is important for blastocoel formation (Abe et al., 1999, Wrenzycki et al., 
005).  Sodium/potassium pumps form on cell surfaces and adenosine triphosphate 
quired to pump sodium into the blastocoel, passively diffusing water into 
the cavity to complete the blastocyst stage (Harvey ., 2002).  Cells are now 
R
b
T
Parrish, University of Wisconsin-Madison: 
http://www.wisc.edu//ansci_repro/lec
 
A
w
w
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ive 
ophoblast growth at day 14-15 (Maddox-Hyttel et al., 2003).  Embryonic 
mplete ‘nuclear 
programming’ that is the cause of the abnormalities observed (Campbell et al., 
complete nuclear reprogramming (Zakhartchenko et al., 2001, Koo et al., 2002).   
differentiated into inner cell mass (fetus) to establish the embryonic disc (Maddox-
Hyttel et al., 2003), and trophectoderm (placenta) (Gardner, 1989).   
 
The embryo “hatches” from the zona pellucida at around day 9 and has explos
tr
development occurs in the oviduct lumen, is free floating, lacks blood supply, and its 
cellular activities are influenced by its environment (Wrenzycki et al., 2005).  This 
occurs for 25 days in bovine development before implantation with the uterine horns. 
 
1.4 MITOCHONDRIAL STRESS 
 
Studies on embryos produced by NT have demonstrated that gene patterns in the 
embryo, fetus and placenta are abnormal and suggest that it is inco
re
2005, Holt et al., 2004, Loi et al., 2001).  Detrimental effects may be not solely be 
due to nuclear reprogramming as similar problems are reported after culture with in 
vitro produced (IVP) embryos (Wilmut et al., 2002).  However, it is suggested that 
inappropriate epigenetic modification of imprinted genes during pre-implantation or 
fetal development may also influence abnormalities, which may be a result of 
in
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, 
which is an important control during development and is thought to be especially 
important for regulating fetal growth (Bowles et al., 2007).  Disturbed imprinting has 
been correlated with abnormalities in NT fetal development (Wrenzycki et al., 2005).  
NT fetuses with developmental abnormalities have displayed aberrant expression of 
imprinted genes known to have important roles in placental development (Wilmut et 
al., 2002, Wrenzycki et al., 2005).  Failure of the placenta to develop and function 
correctly is a principal contributor to NT fetal loss (Koo et al., 2002, Wilmut et al., 
2002, Wrenzycki et al., 2005, Zakhartchenko et al., 2001).  Studies on NT compared 
with normal mice have resulted in placental overgrowth where NT mice displayed 
two- to three-fold larger placentas than control mice (Ogura et al., 2002).  Clones that 
survive to reproductive age have generally healthy normal offspring, that show no 
signs of impaired epigenetic imprinting (Wrenzycki et al., 2005), evidence which 
supports aberrant growth from epigenetic modification rather than genomic.  
 
1.4.2 Epigenetics and Mitochondrial Oxidative Stress 
Epigenetic aberrations that occur due to nuclear reprogramming may result in arrested 
mitochondrial metabolism, creating free radicals or reactive oxygen species (ROS).  
During healthy embryonic development, ROS and antioxidants (e.g. superoxide 
dismutases) in the mitochondria remain in balance.  When the balance is disrupted 
1.4.1 Epigenetic Influence on Nuclear Transfer Development. 
Epigenetics includes gene-regulating activity that is not directly related to the DNA 
sequence itself but primarily based on modifications such as the methylation of the 
DNA sequence, which is crucial for processes such as genetic imprinting (Wrenzycki 
et al., 2005).  Genetic imprinting is a mechanism where a proportion of genes are 
repressed on one of the chromosomes according to the parental origin of the gene
   7
et al., 2005).  
result in 
n increased mutation rate and hence damage to the RNA transcripts or to the 
m synthesize abnormal 
towards an overabundance of ROS, oxidative stress occurs (Agarwal 
The most powerful ROS is the superoxide radical, which is usually detoxified in the 
mitochondria by manganese superoxide dismutase (SOD2) to produce hydrogen 
peroxide which is further degraded to water (Catt and Henman, 2001, Samper et al., 
2003).   
 
ROS will react with DNA, proteins and lipids (Catt and Henman, 2001).  When the 
polyunsaturated fatty acids of lipids are attacked in lipid peroxidation, numbers of the 
acids decrease enough to reduce membrane fluidity.  Increasing the rigidity of the 
membranes can change the function of proteins and enzyme complexes in the 
membrane and also those in the electron transport chain (ETC), creating more ROS 
and damage, reducing the amount of ATP produced and potentially crippling cellular 
function (Catt and Henman, 2001, Tuma, 2001). 
 
ROS can modify DNA bases or induce deletions in the DNA strands (Samper et al., 
2003).  Mitochondrial DNA (MtDNA) is particularly sensitive to ROS damage as it is 
in close proximity to the ETC and thus first in line to ROS exposure, but mtDNA also 
has no protective histone proteins and minimal repair systems (Calabrese et al., 2005, 
Catt and Henman, 2001, Heindleder and Wolf, 2003, Tuma, 2001).  This can 
a
tDNA itself (Catt and Henman, 2001).  Mutated DNA will 
proteins, including those used in the ETC, causing a further increase in ROS and 
exaggerating the damage. 
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n may alter protein structure and function in the mitochondrial ETC, 
reating a disturbance in metabolism and excessive ROS formation.  This is 
bryos (days 1-5), mitochondria are 
resent in low numbers and generate low levels of ATP when compared to late 
n of mitochondria and an increase in the demand of ATP 
are required, the mutated mtDNA will propagate the error to the next generation of 
cells, compounding adverse influences on mitochondrial function (Catt and Henman, 
1.4.3 Mitochondrial Stress Due to mtDNA Mutations 
Aberrant gene expression due to impaired epigenetic imprinting in NT embryonic 
development has been described in studies (Campbell et al., 2005, Vajta and Gjerris, 
2006, Wells, 2003, Wilmut et al., 2002).  Hence it was postulated that disturbed gene 
expressio
c
supported by the observation that NT IVP embryos have a darker cytoplasm due to 
higher lipid content than in vivo produced embryos (Farin et al., 2001).  Studies 
suggest higher lipid content is the result of inefficient metabolism of lipid by 
embryonal mitochondria (Lonergan et al., 2006, Samper et al., 2003). 
 
1.4.4 Mitochondria and ATP in Bovine Embryogenesis 
In mature mammalian oocytes and early stage em
p
morula and blastocyst stage (Farin, 2001, Van Blerkom et al., 1998).  Dysfunctional 
mitochondrial respiration resulting from epigenetic modifications to the ETC, 
increased ROS and mtDNA mutations should be minimized at this early stage due to 
the minimal requirements of mitochondrial ATP production (Van Blerkom et al., 
1998).  However, after day 5 in the bovine, ATP is required for blastulation and 
embryo compaction to blastocyst stage, and increasing amounts of ATP are needed 
due to metabolism requirements throughout gestation (Jansen and Burton, 2004, Van 
Blerkom et al., 1998).  If mtDNA mutations occur in early cleavage stage embryos, 
when significant replicatio
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Tum
f reduced anti-
roliferative growth gene expression (TGFβRI, TGFβRII), ensuing an escape of 
th in NT placentomes, 
2001, a, 2001, Van Blerkom et al., 1998).   
 
1.4.5 Epigenetic Errors and the Influence on Gene Expression and Growth 
It has been suggested that epigenetic effects and perturbed mitochondrial metabolism 
may influence transcription factors (e.g. AP-1, fos, jun, myc, erg-1, SAPK and 
NFkB) (Calabrese et al, 2005) and gene expression patterns which lead to altered 
fetal and placental growth (Fischer-Brown et al., 2005, Harvey et al., 2002, Ravelich 
et al., 2004, Rideout et al., 2001, Zakhartchenko et al., 2001).  Ravelich et al., (2006) 
suggest that these growth alterations in NT pregnancies may be due to the over-
expression of growth factor genes (TGF-β1, -β2, and –β3) as a result o
p
growth-inhibitory signals and consequently increased grow
compared to artificial insemination (AI) controls.  Fischer-Brown et al. (2005) report 
that bovine fetuses that had previously been under considerable mitochondrial stress 
during in vitro production (20% oxygen (O2) culture treatment) had 32% larger 
cotyledons compared to control fetuses (5% O2 culture) at parturition, abnormalities 
which were related back to structural disproportionate allocations of inner cell mass 
(ICM) and trophectoderm (TE) cells.  TE cells consist in a single layer that 
differentiate into trophoblasts and contribute to the formation of placentomes 
(Leunda-Casi et al., 2002).  Koo et al. (2002) also suggest that the abnormal 
placentation observed in NT pregnancies is related to aberrant proportions of NT 
blastocysts having a lower ratio of TE compared to ICM cells. 
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Y 
 
1.5 MITOCHONDRIAL HETEROPLASM
 
Eukaryotic cells contain two distinct genomes, DNA located in the nucleus (nDNA),
and the mitochondria (mtDNA).  During NT, nDNA originates from the donor 
somatic cell while mtDNA originates from the recipient oocyte.  The mtDNA from 
both the donor and recipient oocyte are mixed in the reconstructed embryo (Han et 
al., 2004).  MtDNA heteroplasmy is the presence of more than one type of 
mitochondrial DNA within the same cell, and it has been suggested that this mtDNA 
heteroplasmy may contribute to the failure of NT embryos (Sutovsky et al., 1999, 
Solter, 2000), as it is associated with numerous clinical abnormalities resulting from 
point mutations and mtDNA rearrangements (Van Blerkom et al., 1998).  Differences 
in mtDNA sequences from the recipient and donor during nuclear fusion may 
generate altered amino acid sequence and consequent protein structure, which may 
result in inadequate interaction between the separate subunits of the electron transport 
chain, resulting in deficiencies in oxidative phosphorylation and reduced capacity for 
energy production (Bowles et al., 2007).  There are mixed reports that mtDNA of 
cloned animals were exclusively from the recipient oocyte (Evans et al., 1999, Lanza 
et al., 2000, Loi et al., 2001), and that mtDNA heteroplasmy exists in healthy cloned 
calves (Steinborn et al., 2000, Han et al., 2004). 
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ctrons move from one molecule to 
another is used to pump hydrogen ions across the mitochondrial membrane, finally 
being utilized at ATP synthase to produce ATP (Tuma, 2001).  Some of the oxygen 
that is consumed by the ETC is not completely reduced at the end of the chain to 
form water, but is only partially reduced leaving unpaired electrons to form ROS, 
hydrogen peroxide, superoxide anion and hydroxyl radical (O’brien et al., 2004).  
Figure 1.2 shows the extremely reactive reducing nature of ROS unpaired electrons, 
1.6 OXIDATIVE STRESS 
1.6.1 The Mitochondrion 
Mitochondria are cellular organelles that operate as the cellular “powerhouse”, 
generating energy by the aerobic metabolism of carbohydrates and fatty acids in a 
form that is useful to the cell; ATP (Garrett and Grisham, 1999).  Mitochondria are 
central to diverse cellular functions and contribute to signalling pathways and 
intracellular processes (Dumollard et al., 2007).  Not only do mitochondria produce 
most of the cell’s ATP but they sequester and release calcium, cytochrome c, and 
proteins (Kroemer, 2003).  They also produce reactive oxygen species (ROS), 
intermediary metabolites and are central to cellular processes such as calcium 
transport and distribution and calcium signalling, the regulation of intracellular redox 
potential, control of apoptosis, and possibly the mediators of cellular and organismal 
aging (Balaban et al., 2005).  
 
1.6.2 The Electron Transport Chain and Reactive Oxygen Species 
Four large enzyme complexes lie within the inner membrane of the mitochondria 
making up the ETC using energy substrates and oxygen in a series of reducing and 
oxidizing steps.  The energy released when ele
   12
her molecules, stripping electrons and 
consequently causing the donor molecules to become ROS (Harvey et al., 2002), thus 
ng genomic integrity (Catt & Henman, 2001).   
 fuel essential biochemical reactions, 
which is produced through the ETC via metabolic pathways; glycolysis, using 
these intermediates readily react with ot
upsetting cellular biochemistry, includi
 
 
 
 
Figure 1.2  Reduction of oxygen 
Oxygen reduction occurs one electron at a time, giving rise to unstable intermediates 
that can damage other cellular components.  (Source: Tuma, 2001)  
 
 
1.6.3 Glycolysis and Oxidative Phosphorylation 
Embryo development requires energy (ATP) to
glucose as a substrate, and oxidative phosphorylation, using pyruvate as a substrate 
(Harvey et al., 2002).  During bovine pre-compaction stages (days 1-5) 
approximately 90% of all ATP is derived from oxidative phosphorylation, and as the 
energy demand for ATP increases during compaction and blastulation there is a shift 
in metabolic pathways to glycolysis (Figure 1.3), which coincides with a decrease in 
oxygen tension as the embryo passes along the oviduct to the uterine cavity (Harvey 
et al., 2002, Thompson et al., 2000).  Glycolysis is mainly inhibited pre-compaction 
by a block to the glycolytic enzyme phosphofructokinase.  High citrate levels keep  
this enzyme at low levels until the 8 cell stage, and it is then that phosphofructokinase 
levels must increase at compaction and blastulation to allow glycolysis to produce 
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within the mitochondria and is regulated by environmental oxygen concentration and 
availability of oxygen substrate (Thompson, 2000).   
ATP.  Compromised embryos do not increase levels of phosphofructokinase, 
therefore gylcolysis is minimised and insufficient ATP is created for normal 
embryonic development (Barbehenn et al., 1974). Oxidative phosphorylation occurs 
   14
 
Figure 1.3  Metabolic pathways in early cleavage, and compaction and blastulation 
a)  During the early stages the uptake of glucose is low and uptake of pyruvate is high 
to provide the fuel for oxidative phosphorylation, with the rate of ATP production 
low.  
b)  During compaction and blastulation the uptake of both pyruvate and glucose is 
high to assist increased demand for ATP. (Source: Thompson, 2000) 
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.6.4 The Influence of Oxygen on Oxidative Stress and Embryonic 
Development 
al
termembrane space and transports them back to the matrix to partially uncouple 
ent in vitro (Harvey et al., 2002, Harvey et al., 2004, 
2000, Rieger et 
al., 2002). 
1
Oxygen reaches the embryo by passive diffusion, which is regulated mainly by 
oxygen tension.  Oxygen is a substrate to oxidative phosphorylation and as more 
oxygen is available, the integrity of the mitochondrial membrane complexes is 
compromised when high energy electrons are inappropriately transferred to other 
molecules as they are channelled along the ETC, generating ROS.  Higher levels of 
ROS are exposed to the membrane complexes causing oxidative stress and mtDNA 
damage to levels that may halt embryonic development (Catt and Henman, 2001).  
Results have shown that decreasing the oxygen concentration within the incubation 
atmosphere from 7% O2 pre-compaction to 2% O2 during compaction and 
blastulation is beneficial to embryo development (Harvey et al., 2002, Thompson et 
., 2000).  Energy substrate preference can be manipulated using 2,4-Dinitrophenol 
(DNP), which alters metabolic pathway preference by binding hydrogen ions in the 
in
oxidative phosphorylation, mimicking the inhibition of oxidative phosphorylation 
that occurs under reduced oxygen conditions in vivo (Harvey et al., 2004).  Thus 
oxidative stress and the resulting ROS are minimised, which is shown to be beneficial 
to bovine embryo developm
Thompson, 2000, Thompson and Peterson, 2000, Thompson et al., 
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xidative stress in the mitochondrion a number of protection enzymes 
are expressed above normal levels, including mitochondria specific SOD2, which is a 
major ROS scavenging antioxidant enzyme that is located within the inner 
mitochondrial matrix and converts unstable ROS to more stable forms (Calabrese et 
al., 2005, Tuma, 2001, Watson, 1998).  Heat shock protein 60 (Hsp60) is also 
mitochondria specific and is involved in cell survival as a result of oxidative stress.  
Hsp60 functions as a molecular chaperone by protecting stressed cells with their 
ability to hold, translocate or refold stress-denatured proteins, preventing irreversible 
aggregation with other proteins in the cell, factors that would be detrimental to cell 
survival (Kilmartin and Reen, 2004).  Hsp60 is also viewed as an inter/intra-cellular 
signalling molecule and can activate key cellular activities such as the synthesis of 
cytokines and adhesion proteins (Ranford et al., 2000).  Nollen and Morimoto (2002) 
suggest that heat shock proteins interact with key components of signalling pathways 
that regulate growth and development, and the relationship of these proteins with 
various signalling proteins is critical for normal function of these transduction 
pathways.  A disruption in relative levels of heat shock proteins (too high or low) 
may result in aberrant growth control, developmental malformations, and cell death.  
Nollen and Morimoto (2002) also state that the ability of a cell to properly recognize 
and respond to extracellular signals gives it the ability to know whether to grow, 
divide, differentiate or die; heat shock proteins interact with these signalling 
molecules.  This suggests that altered levels of heat shock proteins in response to 
oxidative stress alters how much an organism integrates and responds to its normal 
physiological signals. 
1.6.5 Mitochondrial Response to Oxidative Stress 
To cope with o
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1.6.6 Effects of Mitochondrial Hsp60 Response 
Heat shock proteins are potent immunogens, implicating Hsp60 as a mediator of 
immune processes (Ranford et al., 2000).  The antigenic properties of heat shock 
proteins may lead to activation of T-cells, which are involved in inflammation and 
autoimmunity (Kamphuis et al., 2005).  This antigenic response may cause an 
interaction with maternal epithelium cells, causing killer T-cells to prevent placental 
trophoblasts burying into the maternal endometrium (Tanaka et al., 2001).  Therefore, 
Hsp60 may be modulating normal placentation processes, causing pathology.  The 
effects of epigenetic aberrations that occur due to nuclear reprogramming may result 
in mitochondrial stress, disruption to the ETC and consequent mitochondrial 
dysfunction.  Hence, relative levels of mitochondrial specific stress proteins, Hsp60 
and SOD2, may be appropriate markers of mitochondrial oxidative stress in NT 
placentomes.  Higher expression of these proteins in NT placentomes compared to AI 
placentomes may indicate that oxidative stress plays a role in placentation 
abnormalities of cloned embyos. 
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SS IN RELATION TO 
g in vitro embryo culture cited as a major influence 
n embryo development, and gene expression (Harvey et al., 2004).  Iwata et al. 
(2000) suggest oxygen tension during in vitro culture to be one of the key factors 
involved in large offspring syndrome (LOS); LOS and placental aberrations are listed 
as the two main developmental dysfunctions associated with NT offspring (Campbell 
et al., 2005, Heyman et al., 2002, Holt et al., 2004, Lee et al., 2004, Vajta and 
Gjerris, 2006).   
1.7 A MODEL OF OXIDATIVE STRE
REPRODUCTIVE PROCESSES: IN VITRO PRODUCED EMBRYOS 
 
1.7.1 In Vitro Culture Erroneous Effects 
Epigenetic modification of imprinted genes is one of the main problems in cloned 
animals (Wilmut et al., 2002, Wrenzycki et al., 2005).  Gutierrez-Adan et al. (2004) 
suggest that preimplantation IVP embryos produce alterations in the regulation of 
transcription of imprinting genes that may result in the abnormalities observed in the 
cloned offspring.  Studies show that in vitro culture alters the expression of imprinted 
genes in murine (Doherty et al., 2000), and bovine embryos (Bertolini et al., 2002).  
Calabrese et al. (2005) suggest that epigenetic effects and perturbed mitochondrial 
metabolism may influence transcription factors due to free radical generation (ROS) 
and oxidative damage.  The post-fertilization in vitro culture environment in which an 
embryo is grown can have dramatic effects on development (Feil et al., 2006), with 
oxygen concentrations used durin
o
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n bovine 
mbryonic development (Harvey et al., 2004, Harvey et al., 2007, Iwata et al., 2000, 
ada ).  Research has focused on the 
conclude that oxygen is a significant component of the bovine 
embryonic environment and hyperoxic (above the normal physiological level of 
oxygen) conditions can influence gene expression and subsequent embryonic 
development, and although it is suggested that oxidative stress and ROS is associated, 
the exact mechanism is not known (Harvey et al., 2004, Iwata et al., 2000, Watson et 
1.7.2 In Vitro Culture at Low Oxygen Concentrations 
Many previous studies have looked at the effects of oxygen concentration o
e
Oyam and Fukui, 2004, Yuan et al., 2003
developmental benefits of using low oxygen concentrations during bovine in vitro 
production, and oxidative phosphorylation uncouplers to demonstrate a significant 
increase in development that is not dissimilar to in vivo uterine tract by creating a 
more favourable intracellular environment with less ROS (Thompson et al., 2000).  
However, exposure to culture with an atmosphere of 2% O2 during post-compaction 
pre-implantation embryo development has adverse consequences such as reduced 
fetal weight and abnormal placental development in the mouse (Feil et al., 2006).   
 
1.7.3 In Vitro Culture at High Oxygen Concentrations 
Recent studies represent embryos cultured under high (20%) and low (7, 5, or 2%) 
atmospheric oxygen concentrations, aimed at defining an oxygen concentration for 
optimal embryonic development to blastocyst stage (Harvey et al., 2004, Harvey et 
al., 2007, Iwata et al., 2000, Yuan et al., 2003).  Embryos appear to be subjected to a 
decreasing oxygen concentration in vivo as they pass through higher oxygen tensions 
in the oviduct (5.3-8.7% O2) followed by a decrease in oxygen tension at day 3 after 
ovulation to about 2% O2 en route to the uterus (Harvey et al., 2007, Yuan et al., 
2003).  Studies 
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the embryo by passive 
ed 
y oxygen concentration in their study. 
al., 1998).  Catt and Henman (2001) state that oxygen reaches 
diffusion, which is controlled by oxygen tension.  Hyperoxic conditions may cause an 
elevated generation of ROS due to the high level of available oxygen, as increased 
levels of oxygen are used as a substrate in oxidative phosphorylation to generate an 
excess of damaging high energy ROS. 
 
Harvey et al., (2007) have investigated Hsp60 and various other cell cycle regulatory 
genes (e.g. glucose transporter 1, hypoxia-inducible factors 1α and 2 α) following 
culture under 20% and 2% O2 to blastocyst stage.  The researchers state that these 
genes may have important roles during embryonic development (e.g. energy 
metabolism, cell cycle regulation) despite expression not being significantly alter
b
 
Fischer-Brown et al. (2005) demonstrated that bovine calves that were cultured under 
20% versus 5% O2 displayed individual cotyledons 32% larger in the group cultured 
under 20% O2, and suggest free oxygen radicals in the culture medium may induce 
damaging epigenetic effects that lead to abnormal placental growth.   
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art A of the study related to the effects of mitochondrial stress in AI, IVP, and NT 
art B of the study investigates the influence of in vitro hyperoxic (20% O2) culture 
ress may induce 
epigenetic effects that lead to abnormal placental growth. 
 
The hypothesis of this work was that mitochondrial oxidative stress has a role in the 
pathology of NT and IVP embryo placentation. 
1.8 THIS STUDY 
 
The aim of this research was to investigate the expression levels of Hsp60 and SOD2 
as mitochondrial stress markers.   
 
P
placentomes.  Significantly higher expression of Hsp60 and SOD2 at the protein level 
in NT compared to AI and IVP would indicate that mitochondrial oxidative stress 
may have a role in the pathology of cloned embryo placentation.  Hsp60 and SOD2 
expression was assessed at different time points of day 50, 100, and 150 of gestation 
to determine if expression levels changed significantly throughout gestation. 
 
P
atmospheric conditions compared to control (7% and 2% O2) without DNP culture 
conditions at day 7 blastocyst and day 15 time points of gestation.  Significantly 
higher levels of expression of cellular and mitochondrial oxidative stress markers at 
protein and mRNA levels would suggest that ROS due to oxidative st
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s of Hsp60, Hsp70 and SOD2 in NT placentomes 
ompared to IVP and AI. 
ern blot 
analysis. 
1.8.1 Objectives of Study 
 
Section A 
Objective 1 – To investigate level
c
Section B 
Objective 1- To produce sufficient quantities of IVP embryos under treatment (20% 
O2) and control (7% and 2% O2) without DNP conditions to enable sufficient 
numbers of embryos for; 
a) Transfer into recipient cows. 
b) An adequate quantity of protein to successfully complete west
Objective 2 – investigate the presence of various stress related markers (Hsp60, 
Hsp70, SOD2, COX2, TIM, GLUT1) at both protein and reverse transcriptase 
polymerase chain reaction (RT-PCR) levels. 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 RIALS 
The antibodies and their sources are listed in Table 2.1 
MATE
 
2.1.1 Antibodies 
Table 2.1  The antibodies used in this study 
Antibody   Product #  Source 
Rabbit anti-Actin    MFCD00145889 Sigma-Aldrich 
Rabbit anti-Hsp70 polyclonal   ab1428  Abcam 
Rabbit anti-Hsp60 polyclonal  SPA-805  Stressgen 
Rab
Dismutase (SOD2) polyclonal  SOD-110  Stressgen 
Goat anti-Triosephosphate Isomerase  
(TIM) polyclonal  
9354  Sigma-Aldrich 
Goat anti-Rabbit IgG  A6154  Sigma-Aldrich 
Sheep anti-Mouse IgG   AP326P  Silenus 
Rabbit anti-Goat IgG  P449  Dakopatts 
 
2.1.2 Antigens 
The antigen and its source is listed in Table 2.2 
Table 2.2  The antigen used in this study 
Antigen  Product #  Source
 
bit anti-Manganese Superoxide  
 sc-22031  Santa Cruz  
Mouse anti-Cyclooxygenase  
(COX2) monoclonal  C
  
Recombinant Rat Hsp60 Protein  SPA 742  Stressgen 
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2.1.3 Buffers
For RNase-free solutions, the water use  with diethyl pyrocarbonate 
A).  0.01% DEPC was added to MQ water (Millipore 
orporation, USA) and incubated at 37°C for 2-3 hours, vigorously shaken a couple 
es during incubation and immediately autoclaved to inactivate the DEPC 
perature unless otherwise 
 
d was treated
(DEPC; Sigma-Aldrich, US
C
of tim
(DEPC treated water).  Buffers were stored at room tem
stated. 
CAPS Transfer Buffer 
25 M tris 
0.192 M glycine 
20% methanol AR 
RNA Loading Buffer 
50% Glycerol (BDH, Poole, UK) 
1 mM EDTA pH 8 
0.25% Bromoph ueenol bl  
 (BDH, Poole, UK) 
uffer
0.25% Xylene cyanol FF
RNA Electrophoresis B  
50 ml 20 x MOPS 
78.5 ormaldehyde  1  ml 37% F
Make up to 1 litre with DEPC water. 
5 x Tris-Borate-EDTA (TBE) Buffer  
1 packet Tris-Borate-EDTA (TBE) Buffer mix (Sigma) 
1 litre MQ water 
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r4 x Separating Buffe  
king Buffer
1.5 M tris (Roche ultrapure) 
0.4% SDS (BioRad electrophoresis grade) 
MQ water 
Add concentrated hydrochloric acid (J.T.Baker) to pH 8.8. 
Stored at 4°C 
4 x Stac  
ultrapure) 
 (Biorad electrophoresis grade) 
ydrochloric acid (J.T.Baker) to pH 6.9 
10 x 
0.5 M tris (Roche 
0.4% SDS
MQ water 
Add concentrated h
Stored at 4°C 
Tank/Running Buffer 
0.025 M tris (Roche ultrapure) 
#1610718) 
3 x S
0.192 M glycine (Bio-Rad 
0.1% SDS (Bio-Rad #1610302) 
MQ water 
DS Laemmli Sample Buffer   
0 Nature 227, 680-685) 
6.8 (Roche ultrapure) 
Add grains of bromophenol blue and stir 30 minutes until fully dissolved.  The 
solution should be a deep blue but opaque.  Store at -4°C. 
Original ref Laemmli UK (197
30% glycerol 
15% β-mercaptoethanol 
6% SDS  
0.1875 M Tris Ph
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ing Buffer6 x Sucrose DNA Load  
sucrose in MQ water. 
t 
10% 
0.25% bromophenol blue 
0.25% xylene cyanol 
40% (w/v) 
Store at 4°C 
 
2.1.4 Detergen
SDS Detergent 
10% (w/v) sodium lauryl sulphate (SDS; Ajax Chemicals, Australia) 
n MQ water at 68°C and adjusted to pH 7.2 with 1 M HCl (BDH, 
 temperature 
2.1.5
DNA
100 bp ladder (1 µg/ µl; Gibco BRL Life Technologies, California, USA) 
 
12.5%
Dissolved i
England) 
Stored at room
 
 DNA Ladder 
 ladder was stored at 4°C. 
2.1.6 Gels 
 Acrylamide Gel 
Separating Gel 
rating buffer 
o-Rad Laboratories), 
2.8 mls MQ water 
2 mls sepa
3.2 mls 30% acrylamide/bis solution (Bi
20 µl ammonium persulphate (APS) (Sigma) 
5.5 µl TEMED (Bio-Rad Laboratories) 
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 Stacking Gel 
1.2 mls MQ water 
0.5 ml stacking buffer  
ion (Bio-Rad Laboratories), 
ium persulphate (APS) (Sigma) 
 µl TEMED (Bio-Rad Laboratories) 
el (2 mini-gels)
0.27 ml 30% acrylamide/bis solut
15 µl ammon
2
7% Acrylamide TBS G  
crylamide/bis solution (Bio-Rad Laboratories), 
S (Sigma) 
oratories) 
1.2% Agarose RNA Gel
2.32 mls 30% a
1 ml 5 x TBE 
6.7 ml MQ water 
100 µl AP
10 µl TEMED (Bio-Rad Lab
 
.2 g ng point (HMP) agarose 
1.8 ml Formaldehyde (BDH, Poole, UK) 
eight Marker 
Precision Plus Protein All Blue Standards (10 µl/application; Bio-Rad Technologies) 
1 rams high melti
88.2 ml DEPC water 
10 ml 10 x MOPS 
 
2.1.7 Molecular W
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mers 
PCR urces are listed in Table 2.3. 
Table 2.3  
 
Prim t Size  (bp) Source
2.1.8 PCR Pri
primers and their so
 The PCR primers used in this study
er Name Primer Sequence Fragmen  
Bovin
transporter 1 forward * CATCGGCTCTGGCATCGTCA 443 Sigma 
Bovin
transp  * CGGCCTTTTGTCTCGGGAACTT  Sigma  
Heat shock protein 70  
forward ** AAGGTGCTGGACAAGTGCCAG 
 GAGGTGATT 488 Sigma  
Heat 
reverse ** ACTTGGAAGTAAACAGAAACG 
 Sigma  
e glucose  
Genosys 
e glucose  
orter 1 reverse
shock protein 70 
 GGTGAAAAA 
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PCR Primer references 
* Bovine sequence is GenBank Accession M60448.  Designed by Dr Rita Lee 
(AgResearch Limited) 
; Gutierrez JA and Guerrioro, V. (1995) Journal of 
ear Transfer Protocol Affects Messenger RNA Expression Patterns 
l
** Original reference from
Biochemistry; 305:197-203, in Wrenzycki C et al., Bology of Reproduction, 65:309-
317 (2001)  Nucl
in Cloned Bovine Blastocysts.  EMBL accession number: U09861. 
  
2.1.9 Solutions 
MQ Saturated Butan-1-o  
 and stand at least 1 hour 
hemilumin iversity)
Butan-1-ol : MQ water 1:1 
Shake vigorously
Enhanced C escence (ECL) (adapted from Yale Un  
Solution A 
5.5 mg Luminol (Sigma A8511)[5-amino-2,3-dihydro-1,4-phthalazinedione] 
60 µl DMSO 
Solution B 
2.8 mg p-coumaric acid (Sigma #9008) 
100 µl DMSO 
Solutions A and B were stored at -80°C 
30% hydrogen peroxide 
0.1 M tris 8.6 
   30
to Maximum Sensitivity Substrate KitSuperSignal®West Fem  (Pierce Biotechnology, 
st Femto luminol/enhancer solution 
Rockford, USA). 
 SuperSignal® We
 SuperSignal® West Femto stable peroxide solution 
Incubate blot with 1.5 ml of each solution for 5 minutes before exposure to  
photographic film. 
20 x MOPS (stock solution) 
400 mM MOPS (Sigma, Steinheim, Germany) 
ate (Barker, Phillipsburg, USA) 
inetetraacetic acid disodium salt (BDH, Poole, UK) 
00 ml.  Adjust to pH 7.0.  Add 10 µl DEPC to 0.5 
hort while and autoclave. 
100 mM Sodium Acet
10 mM Ethylenediam
Make to a final volume of 1
ml ethanol and mix into solution.  Leave a s
10 x MOPS (working solution) 
 th equal volumes of 20 x MOPS and MQ water. 
Gel F
Make up wi
ix Solution 
  (AR grade, Biolab) 
 sphoric acid (MERCK) 
 
10 x 
50% methanol
2% orthopho
RO water 
CAPS 
 
 
Adjust to pH 11 with 10N NaOH.  To make 1 x solution, (usually 4L) add 400 mls 10 
x CAPS to ~ 3L MQ and then add 400mls AR methanol and make up volume to 4L.   
100mM CAPS 
MQ water 
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0.3M Guanidine Hydrochloride in 95% ETOH 
 5.739 g guanidine hydrochloride 
  200 ml 96% ETOH (100% ETOH and 8 ml MQ water)
10 x Tris Buffered Saline (TBS) 
1.5 M Sodium Chloride (Lab Serve) 
500 mM Tris Base (J.T.Baker) 
m chloride in MQ water and adjust pH to 7.4-7.6 with 
.Baker). 
TBS:
Dissolve Tris and sodiu
50-60 mls of concentrated hydrochloric acid (J.T
Tween 
 
 
 
100 ml 10 x TBS 
1 ml 0.1% Tween-20 (BDH Laboratory Supplies) 
Make up to 1 litre with MQ water. 
TBS:BSA:Tween  
10% 10 x TBS 
0.1% bovine serum albumin (Sigma) 
upplies) 
omassie Blue Stain
0.1% Tween-20 (BDH Laboratory S
 
2.1.10 Stains 
Colloidal Co  
ue (Bio-Rad R or G-250) 
 sulphate (BDH) 
Dissolve coomassie blue powder in methanol.  Add orthophosphoric acid, 
methanol and MQ water (previously dissolved) to volume 
0.06% Coomassie Bl
17% ammonium
50% methanol (AR grade, Biolab) 
2% orthophosphoric acid (MERCK) 
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Ponceau S Stain 
 0.1% w/v Ponceau S (Sigma, St. Louis, USA) 
2.1.1
2 x T
 1% acetic acid (J.T.Baker, Phillipsberg, USA) 
 
1 IVP Embryo Media 
CM 199 (500 ml) 
 
 
vacucap 0.2µm filter and store at 4°C.  Lasts for one week. 
EPE 99 (H199) (500ml)
1 x 500 ml sachet TCM 199 mix (Gibco, Auckland, NZ) 
50 gm kanamycin monosulphate (Sigma) 
Filter with a  
H S Buffered TCM 1  
ilton, NZ) 
 B *(Agresearch, Hamilton, NZ) 
l calf serum (Gibco Life Technologies, NZ) 
Bring
Bicar
 250 ml 2 x TCM 199 
 30 ml STOCK H *(Agresearch, Ham
 10 ml STOCK
 50 ml feta
 up to 500 ml with MQ water. 
bonate buffered TCM 199 (B199) (500 ml) 
 250 ml 2 x TCM 199 
*(Agresearch, Hamilton, NZ) 
h, Hamilton, NZ) 
 s, NZ) 
Bring
 
* Det
 50 ml STOCK B 
 3 ml STOCK C *(Agresearc
50 ml fetal calf serum (Gibco Life Technologie
 up to 500ml with MQ water. 
ails of composition confidential. 
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Aspiration Medium (100 ml) 
Mix together: 
 2 ml 20% liquid albumin concentrate (ICPBio, Auckland, NZ) 
5 µ , Hamilton, NZ)  18 l heparin *(Agresearch
Then add to: 
 100 ml H199 
Maturation Medium 
Make up 2 x follicle stimulating hormone (FSH) stock: 
 97.5 ml B199 
 17.6 mg Ovagen (ICPBio, Auckland, NZ) 
gresearch, Hamilton, NZ) 
Then add 50 ml 2 x FSH stock to: 
 50 ml B199 
 100 µl E217B estradiol *(Agresearch, Hamilton, NZ) 
 500 µl leutinizing hormone *(A
HEPES Synthetic Oviduct Fluid (HSOF) 
A llowing stock solutionll fo s are from Agresearch, Hamilton, NZ. 
0.01 ml STOCK D * 
 0.003 (w/v) bovine serum albumin (Sigma) 
Make up to 500 ml with MQ water. 
 0.1 ml STOCK S3 * 
 0.02 ml STOCK B * 
 0.08 ml STOCK H * 
 0.01 ml STOCK C * 
 
 0.01 ml STOCK KC * 
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F MediumIV  
OCK B * 
 serum albumin (Sigma) 
ith MQ water. 
 0.1 ml STOCK S3 * 
 0.1 ml ST
 0.01 ml STOCK C * 
 0.01 ml STOCK D * 
 0.01 ml STOCK KC * 
 0.008 (w/v) bovine
Make up to 500 ml w
 
 
 
 
   35
DS 
.2.1 ction of Embryos 
ll m  of embryos was warmed and equilibrated in a humidified 
% c cubator at 38.5°C, for a minimum of two hours prior to 
se.  perimental work on animals was granted by the Ruakura 
nim aikato Ethics Committee. 
.2.1.1 Oocyte Retrieval 
ovine ovaries were collected into a thermos flask containing sterile saline (0.9% 
/v) at 30°C from the abattoir and brought back to the lab.  Aspiration of oocytes 
from ovaries commenced within 4 hours from ovary collection.  The ovaries were 
drained and rinsed in sterile saline (0.9% w/v) by hand agitation, strained to remove 
excess blood and fluid, and covered again with the warm saline.  Conical tubes (15 
ml) previously warmed in a 30°C incubator, and containing 2 ml of 30°C aspiration 
medium; Hepes-buffered TCM 199 medium (with Earle’s salts; Life Technologies, 
N.Z.) supplemented with 10 µg/ml heparin (from pig intestinal mucosa; Sigma, St 
Louis, USA) and 0.4% (w/v) BSA (affinity column purified, ABRD; Immuno-
Chemical Products, N.Z.). The purpose of the 2 ml of aspiration medium is to keep 
the oocytes as metabolically stable as possible until transfer into maturation drops 
under incubation environment, as described in section 2.2.1.  The tubes were stopped 
with a rubber bung containing an 18 gauge aspiration needle that was connected to a 
Cook VMAR-5000 regulated vacuum pump.  Follicles between 3 and 10 mm in 
diameter were aspirated under vacuum (45 mm Hg).  Follicles were located visually 
2.2 METHO
 
2  In Vitro Produ
A edia used during IVP
5 arbon dioxide in air in
u Approval to undergo ex
A al Ethics Committee and the University of W
 
2
 
B
w
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earing “blister-like” with clear yellow fluid under the follicle 
urface.  Aspiration of follicles released the oocytes from the follicles to be deposited 
e tu ure 2.1).  Aspiration tubes containing 
follicles, with fluid into the tube.  The colour of the tube contents is not follicular 
on the ovary; app
s
into th bes with the follicular fluid (Fig
follicular fluid, oocytes, and cellular debris were changed when ¾ full and held at 
30°C until searching for oocytes (section 2.2.1.2) was completed.   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1  Oocyte aspiration 
Ovaries are aspirated by insertion of a needle into follicles, which is connected to an 
aspiration pump.  The needle is fitted into a rubber bung that is plugged into a conical 
tube.  The oocytes are removed by the vacuum of the aspiration pump from the 
fluid (yellow), but is due to the initial 2 ml of aspiration medium (red) that is in the 
tube at commencement of aspiration.  Follicles appear “blister-like” on the ovary 
surface, as indicated by the arrows. 
Follicles 
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bound together in 
n immature state and are termed cumulus-oocyte complexes (COCs), as shown in 
igure 2.2.  Successful oocyte maturation is achieved by a culture system that allows 
e normal progression of oocyte metabolic activity by provision of essential 
ubstrates and environmental conditions.  Maturation mainly involves RNA 
anscription and protein synthesis, which is necessary for oocyte meiotic completion 
nd for early embryo development. 
 
 
s.ulaval.ca/2002/20201/20201-
2.2.1.2 In Vitro Maturation 
The granulosa cells that surround the mammalian oocyte are known as cumulus cells 
and are important during oocyte development as it is suggested they provide 
metabolic factors and cell to cell communication that are essential for oocyte 
maturation (Boni et al., 2002).  The cumulus cells and oocyte are 
a
F
th
s
tr
a
 
 
 
 
 
 
 
Figure 2.2  Immature cumulus-oocyte complex (COC).   
The immature oocyte is centrally located and surrounded by cumulus cells to form a 
complex.  (Source: http://www.these
1.html#Heading209).  Permission to use Figure 2.2 granted by thesis author, Mario 
Mayes. 
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 the follicular contents using a stereomicroscope 
, 1 µg/ml ovine lutinising hormone (Imuno-
hemical Products, N.Z.), 1 µg/ml oestradiol (Sigma, St. Louis, USA) and 100 µM 
ysteamine (Sigma, St. Louis, USA).  COCs were matured in maturation media in a 
umidified 5% carbon dioxide in air incubator at 38.5°C for 22-24 hours, to the stage 
f development for optimal fertilization success (metaphase 2 of meiosis). 
.2.1.3 In Vitro Fertilization  
permatozoa were prepared from frozen semen obtained from a sire that had been 
haracterized as suitable for in vitro fertilization in the AgResearch laboratory.  
rozen semen straws were purchased by AgResearch Limited that was commercially 
is semen had passed Quality 
tents of two 0.25 ml straws were thawed in 35°C water for 30 seconds, then 
layered upon a Percoll gradient (45%:90%).  Motile spermatozoa were collected after 
COCs were distinguished from
(Nikon SMZ800).  COCs that appeared light in colour with even cytoplasm and 
completely surrounded by corona and unexpanded cumulus cells were selected using 
a 5-50 µl pipettor and sterile pipette tips.  COCs were transferred to a 35 mm dish 
containing HEPES-buffered TCM 199 + 10% (v/v) fetal calf serum (FCS; Gibco 
BRL Life Technologies, N.Z.) medium, washed once in a new dish of H199 + 10% 
(v/v) FCS, and then placed in a dish containing B199 + 10% (v/v) FCS.  Ten COCs in 
10 µl of B199 + 10% (v/v) FCS were transferred into a 40 µl drop of maturation 
medium under 8 ml of Roberts mineral oil (Eatontown, USA).  Maturation medium 
was TCM 199 supplemented with 10% (v/v) FCS, 10 µg/ml ovine FSH (Ovagen; 
Immuno-Chemical Products, N.Z.)
C
c
h
o
 
2
S
c
F
available from Livestock Improvement Cooperation.  Th
Assurance criteria, which included sperm morphology and motility.  
 
 The con
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2-24 hours 
fter maturation had commenced, under the same atmospheric conditions as described 
te .1.2). 
n be visualised.  
nce the oocyte is fertilized it becomes a zygote.  A zygote is the product of the 
centrifugation (Heraeus SEPATECH Labofuge Ae) at 700 x g for 20 minutes at room 
temperature.  The motile fraction was washed in 1 ml HEPES-buffered synthetic 
oviduct fluid (HSOF) medium (Tervit et al., 1972), comprising of 20 mM HEPES, 5 
mM NaHCO3 and 3 mg/ml BSA (fatty acid-free; ICP Bio, Auckland, N.Z.), and 
centrifuged at 200 x g for 5 minutes.  Following removal of the supernatant, the 
fraction was re-suspended in in vitro fertilization (IVF) medium to a final 
concentration of 1 million sperm per ml.  IVF medium was a modified Tyrode’s 
albumin lactate pyruvate medium (Lu et al., 1987), supplemented with 0.01 mM 
heparin (Sigma, St. Louis, USA), 0.2 mM penicillamine (Sigma, Steinheim, 
Germany), and 0.1 mM hypotaurine (Sigma, St. Louis, USA) per L.  Following two 
washes of HSOF and a final wash in IVF medium, 10 µl of IVF medium containing 5 
oocytes was transferred into 30 µl IVF medium drops under 8 ml mineral oil.  Sperm 
in 10 µl aliquots were added to each IVF drop no later than 24 hours after the start of 
oocyte maturation.  Oocytes and sperm were co-incubated for approximately 18 hours 
at 38.5°C under 5% carbon dioxide in air.  Fertilization was performed 2
a
for oocy maturation (section 2.2
 
2.2.1.4 In Vitro Culture 
It is difficult to establish successful fertilization at day 1 of development without 
inspecting each embryo under high magnification; therefore all embryos are treated as 
fertilized until cleavage detection on day 5 when cell division ca
O
fusion of an egg and a sperm. It contains two copies of each chromosome, one from 
each parent.   
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illed with sterile MQ water to humidify and 
arm the gas close to the incubation temperature of 38.5°C, enabling immediate 
in ons for the embryos.  Cold gas flow would lower 
Presumptive zygotes were cultured in vitro for 7 days (day 0 = IVF) in biphasic 
AgResearch Synthetic Oviduct Medium (AgR-SOF).  Biphasic media encompasses 
two phases of media for embryo culture (early SOF [ESOF], and late SOF [LSOF]).  
This caters to the metabolic differences in embryonic development; the early embryo 
(day 1-5) uses amino acids and pyruvate for energy sources, whereas morula and 
blastocysts (day 5-7) rely on glucose and less on amino acids and pyruvate 
(Thompson, 2000).   
 
AgR-SOF is modified from a previously described formulation (Gardner et al., 1994) 
and includes essential and non-essential amino acids (Sigma, Ayreshire, UK) and 8 
mg/ml BSA (ABIVP, Immunochemical Products, Auckland, New Zealand).  
Presumptive zygotes were removed from IVF drops, washed twice in HEPES-
buffered SOF (Tervit et al., 1972) and ten zygotes were cultured under 20% oxygen, 
5% carbon dioxide and 75% nitrogen in ESOF, followed by 2% oxygen, 5% carbon 
dioxide and 93% nitrogen when changed into LSOF drops. 
 
Gas flow was through a dreshel bottle f
w
optimal cubation conditi
incubation temperature and jeopardise embryonic development. Embryos were 
transferred to Late SOF media on day 5 of development (day 0 = day of 
insemination). 
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 on day 7 of development using the criteria of Robertson and 
elson (1998). Grading was done visually under 50 x magnification to identify 
 
 
 7 blastocyst 
Grade one blastocyst with prominent inner cell mass and clear blastocoel, 
characterised by a glossy appearance. 
DNP was left out of LSOF culture media as demonstrated by Thompson et al. (2000).  
DNP is an uncoupler of oxidative phosphorylation and therefore would interfere with 
the study of oxidative stress.  Thompson et al. (2000) showed that at day 5-7 LSOF 
media culture, 2% O2 without DNP gave equivalent embryonic development results 
as 7% O2 with DNP.   
 
Embryos were graded
N
blastocysts from arrested embryos.  Top grade blastocysts had a glossy sheen with a 
distinct membrane around the embryo and clear blastocoel.  Occluded blastocysts 
indicated a decline in quality; more occlusion equated to less quality.  Mixed grade 
blastocysts were washed in HSOF and transferred into a 0.5 ml eppendorf tube with a 
minimal amount of medium.  Tubes were immediately frozen in liquid nitrogen and 
stored at -20°C. 
 
 
Inner cell mass  
 
 
 
 
 
Figure 2.3  Day
Blastocoel 
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SA).  
Q water, and autoclaved RNAse free eppendorf tubes were used.  
he procedure was carried out at room temperature, with the exception of 
centrifugation (Eppendorf Centrifuge 5415D), which was at 4°C.  
.2.2.2 RNA Extraction from Day 7 Blastocysts 
ue to the very low tissue weight (< 1 mg) of the day 7 blastocysts (10 blastocysts 
ple), modifications were made to the TRIzol standard RNA extraction 
rotocol.  This method was very kindly provided by Dr Craig Smith of AgResearch 
o blastocysts in 0.5 ml eppendorf tubes, mixed 
by vortexing and left for 5 minutes.  1 µl of α-globin (5 pg/µl) and 1µl MS2 RNA 
2.2.2 Tissue Preparation 
 
2.2.2.1 TRIzol RNA and Protein Extraction 
RNA and protein was extracted from IVP embryo tissue using TRIzol Reagent 
(Invitrogen, Carlsbad, U
 
When working with RNA, powder-free sterile latex gloves and sterile tips were used 
throughout procedures.  All reagents and solutions were briefly vortexed 
(Supermixer, Lab-Line Instruments) and centrifuged in a bench centrifuge 
(Spectrafuge 16M, Labnet) prior to use, to thoroughly re-suspend and mix 
components. 
 
Isolation was carried out under a fume hood and plastic safety glasses were worn.  
DEPC treated M
T
 
2
D
per sam
p
Limited.  
 
100 µl of TRIzol Reagent was added t
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e TRIzol and blastocysts, and mixed by pipetting.  After 
dding 20 µl of chloroform, the mixture was shaken by hand for 15 seconds before 
000 x g for 15 minutes.  The aqueous 
5 µg/µl, Ambion) was added and mixed gently by hand 
efore leaving for 10 minutes, followed by centrifugation at 12,000 x g for 30 
.2.2.3 Protein Extraction from Day 7 Blastocysts 
 temperature for 3 
inutes to precipitate any remaining DNA.  After centrifugation at 2000 x g for 5 
ppendorf tube.  The tube was then 
hydrochloride in 95% ethanol (wash solution) for 20 minutes, followed by 
entrifugation at 7,500 x g for 5 minutes.  The wash step was repeated using 350 µl of 
(800 µg/µl) were added to th
a
being left for 2-3 minutes and centrifuged at 12,
phase was transferred to a new 0.5 ml tube.  An equal volume of isopropanol (60 µl) 
and 2 µl of linear acrylamide (
b
minutes.  After the supernatant was removed, a final wash of 70% ethanol was added 
to the small pellet and vortexed briefly before centrifugation at 12,000 x g for 10 
minutes.  The RNA pellet was air dried carefully as per standard TRIzol RNA 
extraction, before re-suspension in 8 µl DEPC water.   
 
2
Volumes of reagents used were based on the initial TRIzol reagent administered (100 
µl), due to initial tissue volume, as recommended by TRIzol reagent protocol.  After 
phase separation, the lower red phase was aliquoted into a 1.0 ml eppendorf tube.  0.3 
ml of 100% ethanol was mixed with the aliquot and left at room
m
minutes, the supernatant was transferred to a fresh e
topped up and mixed with 200 µl isopropanol to precipitate the proteins.  After 
leaving for 10 minutes followed by centrifugation at 12,000 x g for 10 minutes, the 
supernatant was discarded.  The remaining pellet was vortexed in 350 µl 0.3 M 
guanidine 
c
guanidine solution two times, with vortexing for 20 minutes each wash.  The samples 
were washed finally in 350 µl 100% ethanol by brief vortexing, and left for 20 
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00 µl of TRIzol was used in the protocol from Dr Craig Smith for 10 blastocysts.  
 samples gave an insignificant 
minutes.  The remaining protein pellet was air dried, then dissolved in 12 µl 1% (w/v) 
SDS solution and stored at -20°C. 
 
2.2.2.4 RNA Extraction from samples of 50 x Day 7 Blastocysts 
The protocol for RNA extraction supplied by Dr Craig Smith is only recommended 
for processing small numbers of blastocysts (under 10 per sample).  Therefore, the 
standard TRIzol RNA extraction protocol was used for the samples that equated to 50 
blastocysts per sample.  One modification to the standard protocol was made; the 
addition of glycogen to assist with precipitation of RNA.  
 
1
Due to the small mass of 50 blastocysts, weighing the
weight to base volume calculations on; therefore the amount of TRIzol used for 10 
blastocysts was used as a reference point in the decision to use 200 µl TRIzol for 50 
blastocysts. 
 
200 µl of TRIzol was added to each 50 x blastocysts sample in 1.0 ml eppendorf 
tubes before briefly shaking by hand.  Samples were incubated for 5 minutes to 
dissociate the nucleoprotein complexes and 40 µl of chloroform was added.  
Eppendorf tubes were capped securely before vigorous shaking by hand for 15 
seconds and incubation for 3 minutes.  Samples were centrifuged at 12,000 x g for 15 
minutes.  Following centrifugation the mixture was separated into a lower red, 
phenol-chloroform phase (protein), an interphase (DNA), and a colourless upper 
phase (RNA). 
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orf tube.  
 µl of 10 µg/µl 
A.  
iefly air-dried for 5-10 minutes, taking care not to let the pellet dry 
ompletely as this would decrease its solubility.  The semi-dried pellet was then 
The aqueous phase from the initial phase separation of the embryo tissue was 
transferred to a fresh 1.0 ml eppend
 
Due to such a low quantitiy of RNA available for extraction, 1
glycogen (Roche Diagnostics, Germany) was added with 100 µl isopropenol at the 
precipitation stage of RNA isolation.  Glycogen is insoluble in an ethanol solution 
and forms a precipitate that traps target nucleic acids (Harju & Peterson, 2001).  
Glycogen is a high molecular weight molecule which aids with pellet formation 
during centrifugation, facilitating the handling of target RN
 
Samples were incubated for 10 minutes and centrifuged at 12,000 x g for 10 minutes.  
The supernatant was carefully removed, taking care not to disturb the gel like pellet 
on the bottom and side of the tube.  This was followed by a wash with 300 µl of 75% 
ethanol by vortexing to mix and centrifugation at 7,500 x g for 5 minutes.  The pellet 
was then br
c
solubilised by adding DEPC water and mixing by passing the solution up and down a 
pipette tip, and incubating for 10 minutes in a 55°C water bath.  As no initial weights 
were established, an estimate of 12 µl of DEPC water was added to each RNA pellet.  
The samples were stored at -80°C. 
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cysts per sample, were conducted using 
e TRIzol protein isolation protocol (section 2.2.2.3).  200 µl of TRIzol was used for 
c rod to grind the embryo.  The plastic rod was 
washed thoroughly between tissue samples with DEPC water.  The amount of DEPC 
water added to the resulting RNA pellet also corresponded to the weight of the 
original embryo, 1 µl DEPC water per mg of embryo, which varied between each 
individual sample from 10-120 µl.  The samples were stored at -80°C. 
2.2.2.5 Protein Extraction from Samples of 50 x Day 7 Blastocysts 
Protein extraction from the pools of 50 blasto
th
50 blastocysts and other reagent volumes were calculated according to TRIzol 
protocol recommendations; 60 µl 100% ethanol (DNA precipitation), 300 µl 
isopropyl alcohol, 400 µl 0.3 M guanidine hydrochloride in 95% ethanol, 300 µl 
100% ethanol.  After air-drying the remaining pellets for 5-10 minutes, the protein 
pellets were dissolved in 40 µl 1% (w/v) SDS according to TRIzol protocol (section 
2.2.2.3).  Samples were then stored at -20°C. 
 
2.2.2.6 RNA Extraction of Day 15 of Gestation Tissue Samples 
The modified (addition of glycogen) TRIzol protocol (section 2.2.2.4) was used for 
RNA extraction of day 15 of gestation tissues.  The initial volume of TRIzol was 
adjusted according to embryo weight, which varied between 200 µl for 8 mg of 
embryo, to 1 ml for 110 mg of embryo.  Calculations for other reagents in the 
procedure were based on these initial TRIzol volumes for each individual sample; 0.2 
ml chloroform per 1.0 ml of TRIzol, 0.5 ml isopropenol per 1.0 ml of TRIzol. 
 
TRIzol was added to each embryo in 1.5 ml eppendorf tubes, and tissue was 
homogenised using a sterile plasti
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ol (section 2.2.2.3).  Reagent volumes 
ere calculated according to TRIzol protocol recommendations: 0.8 ml isopropanol, 
0% ethanol. The 
 kindly 
onated by AgResearch Limited.  Blastocysts were made using standard AgResearch 
2.2.2.7 Protein Extraction of Day 15 of Gestation Tissue Samples 
The lower red protein phase of the processed samples was aliquoted into a 1.5 ml 
eppendorf tube following dissociation of the nucleoprotein complexes.  0.3 ml of 
100% ethanol was mixed with the aliquot and left at room temperature for 3 minutes 
to precipitate any remaining DNA.  After centrifugation at 6,500 x g for 5 minutes, 
the supernatant was transferred to a fresh 1.5 ml eppendorf tube.   
 
Protein extraction from the day 15 of gestation tissue samples was conducted using 
the standard protein isolation TRIzol protoc
w
1 ml 0.3 M guanidine hydrochloride in 95% ethanol, 0.8 ml 10
remaining protein pellet was air dried, then dissolved in approximately 0.5 ml 1% 
(w/v) SDS solution and stored at -20°C. 
 
2.2.2.8 Fetal and Maternal Cotyledon, and Early Gestation Protein Samples 
TRIzol extracted proteins from bovine fetal and maternal cotyledons (day 50, 100, 
150 of gestation), and also bovine early gestation (days 20-31) embryos were
d
in vitro produced methodology, and processed using TRIzol extraction protocols, 
with some modification as described in this section. 
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ed into a Life Technologies Horizon 11.14 
orizontal Gel Electrophoresis Apparatus to set.  RNA electrophoresis buffer (section 
 was 
ining by ultraviolet light, using a 
BIO-RAD Gel Doc 1000 imaging densitometer.  The presence of 18S and 28S bands 
verified RNA integrity.  Sample aliquots were stored at -80°C. 
2.2.2.9 RNA Verification 
NanoDrop® was used to determine RNA quantities by measuring 1 µl of each 
sample.  NanoDrop ND-1000 UV-Vis spectrophotometer (NanoDrop Technologies) 
is a full-spectrum spectrophotometer that measures samples by employing surface 
tension to hold the sample in place.  Absorbance was analysed at A280 (280nm) 
using the recommended reference type 1 abs = 1 ng/µl.   
 
2.2.2.10 Visualisation of RNA integrity 
A 1.2% agarose gel was prepared by microwaving 1.2 gram of high melting point 
agarose (Seakem LE Agarose, Rocklan, USA) with 88.2 ml DEPC water until melted 
(1-2 minutes).  The agarose solution was cooled to approximately 60°C before 
mixing well with 1.8 ml formaldehyde (BDH, Poole, UK) and 10 ml 10 x MOPS 
(section 2.1.9).  The gel was then pour
H
2.1.3) was added to the gel and allowed to equilibrate for 10 minutes.  1 µg RNA
mixed by pipetting with 5 µl RNA loading buffer (section 2.1.3) and samples were 
loaded onto a gel and run at contstant 90 mA until the dye front was ½ to ¾ of the 
way down the gel (approximately 1 hour).  The gel was then gently rocked in 
ethidium bromide (BDH Laboratory Supplies, UK) for 20 minutes.  Product identity 
was confirmed by detection of ethidium bromide sta
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yacrylamide Gel Electrophrosis 
ance of major proteins in a 
ample, and to determine the distribution of proteins among fractions.   
hich was prepared bi-
weekly, 5.5 µl TEMED (Bio-Rad Laboratories, Hercules, USA).  The gels were 
overlaid with 60 µl of MQ water saturated butan-1-ol (BDH Laboratory Supplies, 
Poole, UK) for 20 minutes at 30°C.  The butan-1-ol was rinsed off twice with MQ 
2.2.3 Sodium Dodecyl Sulphate Pol
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is a 
method for separating proteins by electrophoresis using a discontinuous 
polyacrylamide gel as a support medium and sodium dodecyl sulphate (SDS) to 
denature the proteins.  Protein separation by SDS-PAGE can be used to estimate 
relative molecular mass, to determine the relative abund
s
 
2.2.3.1 12.5% Acrylamide Gel Preparation 
Preparation required casting two different layers of acrylamide gel between glass 
plates, using a Bio-Rad cassette system. The lower layer (separating gel) is 
responsible for actually separating the polypeptides by their molecular weight. The 
upper layer (stacking gel) includes the sample wells and concentrates the protein 
present in the sample volume.  
 
Casting stands were required to prepare mini-gels.  Each gel incorporated 8 x 10 cm 
and 6.5 x 10 cm glass plates that had been cleaned with methanol, two 0.75 mm 
teflon spacers and a well former comb.  12.5% acrylamide gels were used to separate 
polypeptides with molecular weights between 10 and 250 kDa.  The separating gels 
contained 2.8 ml MQ water, 2 ml separating buffer (section 2.1.3), 3.2 ml 30% 
acrylamide/bis solution (Bio-Rad Laboratories, Hercules, USA), 20 µl 10% (w/v) 
ammonium persulphate (APS) (Sigma, Steinheim, Germany), w
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el.  A 4% 
anoDrop was used to estimate protein levels in the samples.  To estimate protein 
 at A280 (280nm) using 2 µl aliquots 
centration to total 150 µl aliquots, before heating at 
5°C for 5 minutes. Heating ensured proteins were denatured to obstruct tertiary and 
water and the 1.5 cm stacking gel cavity was dried with paper tow
acrylamide stacking gel containing 1.2 mls MQ water, 0.5 ml stacking buffer (section 
2.1.3), 0.27 ml 30% acrylamide/bis solution, 15 µl 10% (w/v) APS, and 2 µl TEMED 
was added to the separating gel with a 10 lane comb, and left at room temperature for 
15 minutes.   
 
2.2.3.2 Protein Estimation 
N
concentration, sample absorbance was analysed
from each individual sample and the recommended reference type; 1 abs = 1mg/ml. 
 
2.2.3.3 Sample Preparation for SDS-PAGE 
Protein samples were prepared for SDS-PAGE by adding 3 x Laemmli buffer (section 
2.1.3) at 2:1 protein/buffer con
9
secondary structure, enabling binding of the SDS to the protein, aiding efficient 
polypeptide separation through the acrylamide gels.  Prepared samples were cooled to 
room temperature and stored at -20°C. 
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 2.1.3) at 20 mA per gel for ~ 45 minutes until the dye front was almost 
t the end of the gel.  Initially, gels were fixed in fixing solution (section 2.1.9) for 
r ght staining with colloidal Coomasie stain (section 
d 
roteins were transferred to a 9 x 12 cm nitrocellulose membrane sheet (PALL Life 
r (section 2.1.3) for 10 minutes.  Two 20 x 15 
cm nylon fibre pads were pre-soaked with 1 x CAPS buffer in a plastic transfer 
cassette before layering one fibre pad, followed by two sheets of 3mm filter paper.  
The pre-wetted membrane was then placed on the filter paper and the gels were 
carefully laid on top of the membrane before layering with two more sheets of paper.  
Air bubbles were removed by gently rolling a glass rod over the surface of the filter 
paper before placing the final fibre pad on top.  After locking the cassette, transfer 
took place in a transfer apparatus (Bio-Rad Trans-blot Cell) with 1 x CAPS buffer.  
2.2.3.4 Protein Separation and Estimation 
After loading volumes of protein samples using protein estimation acquired from 
NanoDrop, which equated to 20 µg/lane into the gel lanes, samples were run by 
electrophoresis in a Bio-Rad Mini PROTEAN 3 Cell tank (USA) with 1 x running 
buffer (section
a
one hou followed by overni
2.1.10) to verify equal loading of the protein samples.  The gel was rinsed for 15 
minutes three times with MQ water.  When visually satisfied that samples were of 
relatively even protein levels, the staining step was emitted for following gels, an
p
Sciences, Pensacola, USA).    
 
2.2.4 Western Blot Analysis 
 
2.2.4.1 Protein Transfer to Nitrocellulose Membrane 
The nitrocellulose membrane was wet with MQ water for 5 minutes, and then 
equilibrated in 1 x CAPS transfer buffe
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ither at 20 V overnight, or 50 V for 2 
rimary antibody incubation was either at room temperature for 2 hours or overnight 
oncentration diluted in TBS:BSA:Tween (section 
.1.9).  The membrane was then rinsed 3 x in TBS:Tween for 3 x 5 minute washes.  
 radish peroxidase and was 
Transfer was performed at a constant voltage: e
hours.  After transfer, the membrane was stained with ponseau S stain (section 
2.1.10) for ~ 2 minutes before rinsing 3 times with MQ water and scanning of the 
image.   
 
2.2.4.2 Nitrocellulose Membrane Blocking 
The membrane was blocked with 1.2 gram of non-fat milk powder (Anchor, N.Z.) in 
30 ml TBS:Tween (section 2.1.9) for either 2 hours at room temperature or overnight 
at 4°C, followed by 3 x 5 minute washes in TBS:Tween.  Blocking destains the 
ponceau S from the membrane. 
 
2.2.4.3 Immunodetection 
P
at 4°C with an optimised primary c
2
The secondary antibody used was conjugated with horse
dependent on which species the primary antibody was raised in.  Secondary antibody 
incubation was at room temperature for 1-2 hours, using a concentration optimised 
for the primary antibody, diluted in TBS:BSA:Tween.  After incubation, the 
membrane was again washed in 2 x 5 minute washes of TBS:Tween, followed by 2 x 
5 minute washes of TBS (section 2.1.3) alone.  
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isualise the bound antibody by adding the ECL mix to the membrane in a 
esh container and gently swirling the solution over the membrane for 2 minutes.   
ing ECL was insufficient when trying 
 added and agitated gently for 5 minutes, continuing 
ith the standard developing procedure as follows. 
ernight, and kept for subsequent re-
probing. 
2.2.4.4 Chemiluminescence Detection  
Enhanced chemiluminescence (ECL; 24 µl of solution A and 4 µl of solution B in 10 
mls 0.1M Tris, pH 8.6, with 3 µl 30% hydrogen peroxide solution) detection was 
used to v
fr
The standard method of chemiluminescence us
to detect a signal from the day 7 blastcyst blot.  Therefore SuperSignal® West Femto 
Maximum Sensitivity Substrate Kit was used successfully to detect a signal.  1.5 ml 
each of luminol/enhancer solution and stable peroxide solution were mixed in a clean 
container to which the blot was
w
 
The membrane was drained of ECL solution and placed between plastic sheets in a 
light-free X-ray cassette.  In a photography darkroom, photographic film (Kodak 
BioMax XAR) of adequate size to cover the membrane was placed into the cassette 
on top of the membrane and exposed for a given amount of time.  Initially the first 
time exposure was for 2 minutes.  Subsequent exposures were increased or decreased, 
dependent on the degree of signal after 2 minutes, to gain an optimal signal for 
analyzing.  The film was developed in an automatic X-ray film processor (100-Plus, 
All-Pro Imaging, NY, USA).  After X-ray development, the membrane was rinsed 
briefly in TBS, dried between filter paper ov
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miluminescent Blots 
d 
hod to evaluate the differences in 
eans between two groups; treatment and control groups were employed to 
2.2.4.5 Quantitation of Film-Based Che
Following chemiluminescent exposure, bands on the photographic film were scanned 
with a Bio-Rad GS-800 calibrated densitometer.  Band intensity was assessed using 
Bio-Rad Quantity One software, which measures pixel density of a specified area.  
The background is subtracted from the pixel density within the area of the measure
region, giving an arbitrary unit (AU). Proteins of interest were normalised against 
actin (house-keeping protein) by division with actin AU.  The protein of interest 
AU/actin AU results represent a quantified result of the protein expression.   
 
2.2.4.6 Statistical Analysis 
The students t-test is the most commonly used met
m
determine the significance of the levels of various oxidative stress associated 
proteins.  Students t-test was ideal because it allowed for the uncertainty associated 
with estimating the variance from a small group size (<30).  Variance from a small 
sample size is more likely to be unrepresentative of the whole population. 
 
If the resulting students t-test was <0.05 it could be suggested that there was a 
significant difference between the control and treatment levels of protein expression.  
However, if the result was >0.05 it could be decided that there were not significant 
levels of protein expression between the control and treatment sample groups.   
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lotted on bar graphs, 
cription.  
mplification of the resulting cDNA is achieved using polymerase chain reaction. 
irst-Strand 
uffer, 2 µl 0.1 M DL-Dithiothreitol (DTT), and 1 µl 10 mM Deoxyribonucleotide 
e 2.5 
µl removed for the negative control only had 0.75 µl added to compensate.  After 
incubating for 1 hour at 42°C, the samples were then inactivated for 10 minutes at 
68°C. 
Group averages of treatment and sample populations were then p
incorporating standard error of the mean bars for a visual interpretation of the western 
blot analysis results. 
 
2.2.5 Reverse Transcription-Polymerase Chain Reaction  
Reverse transcription-polymerase chain reaction (RT-PCR) is a sensitive technique 
for mRNA detection.  In the first step of RT-PCR, complementary DNA (cDNA) is 
made from a messenger RNA template through the process of reverse trans
A
 
2.2.5.1 Reverse Transcriptase and First-Strand cDNA Synthesis 
Reverse transcription was carried out using a Perkin Elmer Cetus DNA Thermal 
Cycler.  An 11 µl reaction volume comprising of DEPC water and 1 µg RNA was 
added to a nuclease-free 0.5 ml eppendorf tube, along with 1 µl 3’RACE random 
primer.  After vortexing to mix, the volume was heated at 70°C for 10 minutes and 
chilled on ice for 5 minutes, followed by brief centrifugation.  4 µl 5 x F
B
triphosphate (dNTP) per sample were combined, mixed and added to each sample 
tube.  2.5 µl was taken from two of the sample tubes to use as a negative control.  The 
tubes were incubated at 42°C for two minutes then 1 µl of M-MLV reverse 
transcriptase was added and mixed by gentle pipetting.  The samples that had th
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 section of DNA.  There are three major steps in a PCR, 
enaturation, annealing, and extension, which are repeated for a set number of cycles. 
Express), which heats 
er, 
nd 0.2 µl fast-start taq polymerase (Applied Biosystems, Foster City, USA), was 
n product.  The 
 BIO-RAD Gel Doc 1000 imaging densitometer. 
2.2.5.2 Polymerase Chain Reaction 
The purpose of a polymerase chain reaction (PCR) is to make a huge number of 
copies of a specific
d
This was done on an automated cycler (Thermo Hybaid PCR 
and cools the tubes with the reaction mixture in a very short time. Per sample, PCR 
reaction mix consisting of 1.25 µl 10 x PCR buffer + 15 mM magnesium chloride, 
1.25 µl 2 mM dNTP, 1.25 µl of each forward and reverse primers (gene of interest; 
e.g. HSP70), 0.5 µl of 12.5 mM magnesium chloride, 6 µl autoclaved, distilled wat
a
added to an eppendorf tube, followed by 1 µl of cDNA reactio
samples were then heated at 94°C for 5 minutes to denature, followed by a pre-
determined number of cycles of 94°C for 30 seconds, 65°C for 30 seconds, 72°C for 
20 seconds, and finally held at 4°C. 
 
2.2.5.3 DNA Gel 
Mini-gels were assembled and made using 7% acrylamide TBS gels.  2 µl of 6 x 
sucrose DNA buffer (section 2.1.2) was added to the 12.5 µl PCR samples and 
pipetted to mix.  5 µl of these samples was added to the gel lanes, including 2 µl of 
molecular weight marker (100bp) in one lane.  Samples were run at 20 V/gel with 
TBS buffer until the dye-front was near the bottom of the gel, and then rocked gently 
in ethidium bromide (BDH Laboratory Supplies, UK) for 20 minutes.  Product 
identity was confirmed by detection of ethidium bromide staining by ultraviolet light, 
using a
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2.2.6 Embryo Photographs 
Several embryos were randomly chosen as representatives of their respective 
treatment group and fixed in 4% PFA for 10 minutes at room temperature, before 
placement in 400 µl drops of 0.1% Thimerosay in PBT, in a 4 well plastic dish before 
being photographed.  Embryos were placed on glass slides and images were captured 
using a Leitz DMIRB inverted microscope, with a SciTec RTSE spot camera, at 100 
x and 200 x magnification. 
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CHAPTER 3: RESULTS 
Placental abnormalities in NT cloned fetuses are common and most studies have 
suggested that epigenetic errors during the cloning process may be responsible for 
disruption cellular processes.  One may speculate that one of these processes is 
mitochondrial metabolism, causing oxidative stress and a high expression of stress 
proteins.  
 
This chapter aims to determine if unusually high levels of stress proteins are 
expressed in bovine cloned fetuses, which may interfere with cellular processes, 
altering the physiology and function of bovine NT cloned placentomes.  The 
expression levels of proteins specific to oxidative and cellular stress will be studied at 
the protein level of bovine placentomes. 
 
SDS-PAGE and western blot analysis were chosen as the technique for protein 
identification to compare expression levels of Hsp60, Hsp70, and SOD2, in AI, IVP, 
and NT placentomes at time points of day 50, day 100, and day 150 of gestation. 
 
SECTION A 
 
3.1 INVESTIGATION OF HSP60 EXPRESSION BETWEEN AI, IVP 
AND NT FETAL AND MATERNAL COTYLEDONS 
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3.1.1 Protein Sample Preparation 
rotein samples from a previous trial that were extracted using a standard TRIzol 
method (section 2.2.2.3) were kindly provided by AgResearch Limited, and stored at 
dorf tubes.  These samples were identified as Trial 1 for the purpose of 
anoDrop was used to determine protein levels of the samples.  NanoDrop ND-1000 
g/ml. 
lent 
amounts of protein for each sample lane were loaded onto the SDS-PAGE gels, as 
shown in Figure 3.1.  Using recorded NanoDrop sample measurements, calculations 
identified the volume of individual sample and 3 x Laemmli buffer aliquot required 
P
-20°C in eppen
this study. 
 
N
UV-Vis spectrophotometer (NanoDrop Technologies) is a full-spectrum 
spectrophotometer that measures 2 µl samples by employing surface tension to hold 
the sample in place.  To determine protein concentration using NanoDrop, sample 
absorbance was analysed at A280 (280nm) using the recommended reference type of 
1 abs = 1 m
 
In preparation for this investigation, samples were thawed at room temperature before 
dilution at 2:1 ratio of sample to 3 x Laemmli buffer, to give a total volume of 150 µl.  
Aliquots were incubated at 95°C for 5 minutes for denaturation and undoing of 
tertiary structure to enable binding of Laemmli buffer to the protein, and then stored 
at ¯20°C.   
 
3.1.2 Protein Separation   
SDS-PAGE was employed using 12.5% acrylamide gels and 20 µg of protein per lane 
to check that the levels of protein did not vary between samples, and equiva
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at 20mA/gel until the dye front was within 
peared to have an even density of protein bands between sample lanes 
igure 3.1).  This result indicated that NanoDrop was an accurate way of measuring 
f amino acids to absorbance will be similar for all samples.  The 
sults of the SDS-PAGE gel in Figure 3.1 indicate that despite the different sample 
for 20 µg of protein.  The gels were run 
0.5 cm of the gel end.  Gels were stained overnight with coomassie blue stain (section 
2.1.10), which followed with three 15 minute rinses in MQ water.  This procedure 
gave visual verification of even quantities of protein between each sample, as the gels 
visually ap
(F
protein levels in each sample.  However, this accuracy is conditional upon samples 
being from the same tissue types.  As NanoDrop estimates protein based on the 
absorbance at 280 nm by the aromatic amino acids in the samples, different proteins 
will have different proportions of these amino acids in them, which will affect 
absorbance.  If protein samples come from the same type of tissue (e.g. placentomes), 
the contribution o
re
groups, the distribution of the major protein bands in each lane was similar.   
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Figure 3.1  SDS-PAGE gel verification of protein bands by Coomassie Blue staining. 
Protein samples (20 µg) from day 150 maternal cotyledons were run on SDS-PAGE 
12.5% acrylamide gels.  Lanes are as follows: 1-5: AI day 150 maternal cotlyedons, 
6-9: IVP day 150 maternal cotyledons, 10-18: NT day 150 maternal cotyledons.  
Molecular weights were assigned based on previous gels with molecular weight 
markers.  Major protein bands were present at molecular weights of 10, 40, and 60 
kDa, as shown. 
 
3.1.3 Protein Transfer 
Upon satisfaction that protein concentration was even between samples (Figure 3.1), 
proteins separated on a 12.5% acrylamide gel were transferred onto a nitrocellulose 
membrane via a transfer apparatus (Bio-Rad Trans-blot Cell), as described in section 
2.2.4.1.  Staining with Ponceau S allowed visual verification that the proteins had 
been transferred to the membrane successfully (Figure 3.2).  All major protein bands 
 
 
 
AI IVP NT
60 kDa 
40 kDa 
 
 
 
10 kDa 
1     2     3     4     5     6     7     8     9    10   11   12   13   14   15   16   17   18 
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ere seen to be transferred onto the membrane from the gel in Figure 3.1.  Again, 
ere appears to be no distinct visual difference between the separation and density of 
AI, IVP, and NT bands. 
 
 
 
 
 
 
 
 
 
 
 
llows: 1-5: AI day 150 maternal cotlyedons, 6-9: IVP day 150 
aternal cotyledons, 10-17: NT day 150 maternal cotyledons.  Major bands were 
w
th
AI IVP NT
60 kDa 
 
 
40 kDa 
10 kDa 
 1    2   3   4   5   6    7   8   9   10  11 12  13  14  15 16 17 
 
Figure 3.2  Nitrocellulose membrane stained with Ponceau S. 
Ponceau S stained transfer blot of day 150 maternal cotyledons 2 hours at 50 volts.  
Lanes are as fo
m
seen at 10, 40, and 60 kDa.   
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 section 2.2.4.2 for 2 hours at room temperature, prior to 
robing with polyclonal anti-Hsp60 (1:10,000 dilution) for 2 hours at room 
mperature. 
The blot showed double bands at around the 60 kDa mark (Figure 3.3A), resulting in 
an inability to confirm which immunoreactive band was in fact Hsp60.  The NT day 
50 fetal cotyledon blot was repeated using the same samples and probed with fresh 
antibody after overnight blocking at 4°C instead of 2 hours at room temperature.  5 µl 
Hsp60 antigen (10 µg) was also used as a positive control to confirm Hsp60 
immunoreaction.  Background bands became eliminated (Figure 3.3B), suggesting 
that less background signalling and a clear target protein band (Hsp60) could be 
obtained by overnight blocking.   
3.1.4 Western Blot Analysis 
NT day 50 fetal cotyledon proteins were transferred to a nitrocellulose membrane and 
blocked as described in
p
te
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ble bands were present between molecular weight 
markers of 50 and 75 kDa in lanes 2-9.  Lane 1: molecular weight marker.  B lane 1: 
molecular weight marker, lane 2: Hsp60 antigen, lanes 3-10 NT day 50 fetal 
cotyledons.  The single band was evident at 60 kDa, the same molecular weight as the 
positive control in lane 1, confirming Hsp60 identity. 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3.3  NT fetal cotyledons at day 50 of gestation probed with anti-Hsp60. 
A NT day 50 fetal cotyledons dou
A
75 kDa 
1     2      3      4       5      6      7      8      9 
50 kDa 
B
75 kDa 
1     2      3     4     5     6      7     8     9    10 
50 kDa 
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.2 INVESTIGATION OF MITOCHONDRIAL STRESS IN BOVINE 
ETAL AND MATERNAL COTYLEDONS. 
estern Blot Analysis (Trial 1 samples) 
rial 1 protein samples were kindly provided by Agresearch Ltd and had previously 
een extracted using the TRizol method from fetal and maternal cotyledon tissues at 
me points of days 50, 100, and 150, with IVP and NT treatment groups, and AI as 
e control group.   
DS-PAGE 12.5% acrylamide gels were run using 20 µg of protein per sample in 
ach lane as described in section 2.2.3.  Following transfer to a nitrocellulose 
embrane (section 2.2.4.1) and overnight blocking with 1.2g non-fat milk powder in 
hsp60 
brane for 2-4 minutes on x-ray 
film. 
3
F
 
3.2.1 Hsp60 W
T
b
ti
th
 
S
e
m
30 ml TBSTween, expression of Hsp60 was determined with anti-rabbit 
polyclonal antiserum (Stressgen, Victoria, Canada).  Anti-rabbit IgG peroxidise-
conjugated antibody was used as the secondary antibody.  Chemiluminescent 
detection of the targeted protein was after a 2 minute incubation with ECL and the 
light signal being detected after exposure of the mem
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 Blot of maternal cotyledons at day 150. 
Blot was probed with polyclonal Hsp60 (Stressgen, Canada.  1:10,000) and Actin 
a, U.S.A.  1:10,000).   
s.  Sample groups fetal cotyledons at day 50, 100, 150, and maternal cotyledons 
at day 50, 100, 150 are presented in Figure 3.5 after western blot and students t-test 
analysis. 
 
Hsp60 60 kDa 
Actin 42 kDa 
 
Figure 3.4  Western
(Sigm
 
Chemiluminescent detection of the targeted protein (Hsp60) was captured on 
photographic film after 30 seconds of exposure to the membrane bound with 
antibodies.  Actin was used as a housekeeping protein for normalisation of the level 
of Hsp60 on each of the blots for fetal and maternal cotyledons at the different time 
points (Figure 3.4).  Following film exposure, Quantity One software provided 
comparative quantitation of the results, as described in section 2.2.4.5.  This enabled 
statistical analysis with students t-test to compare protein expression between sample 
group
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significantly lower than AI, p = 0.03.  B  AI (n = 4), IVP (n = 4), NT (n = 6) fetal 
C  AI (n = 
5), IVP (n = 4), and NT (n = 8) fetal cotyledons at day 150.  D  AI (n = 5), IVP (n = 
3), and NT (n = 10) maternal cotyledons at day 50.  NT was significantly higher than 
AI and IVP, p = 0.03.  E  AI (n = 4), IVP (n = 4), and NT (n = 6) maternal cotyledons 
at day100.  F  AI (n = 5), IVP (n = 4), and NT (n = 8) maternal cotyledons at day 150.  
NT was significantly lower than AI, p = 0.03.  * p ≤ 0.05, ** p ≤ 0.01.  Bars represent 
standard error of the mean. 
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Figure 3.5  Hsp60 expression in AI, IVP, and NT fetal and maternal cotyledons at 
time points of day 50, 100, 150 of gestation, from trial 1 proteins. 
A  AI (n = 5), IVP (n = 3), and NT (n = 10) fetal cotyledons at day 50.  IVP was 
cotyledons at day 100.  NT was significantly higher than AI, p = 0.009.  
 Fetal cotyledons Day 150
1.00
0.00
0.25
treatment
0.50
0.75
nd
 in
te
ns
it
AI IVP NT
ba
y
Fetal cotyledons Day 50
0.0
0.4
0.8
1.2
1.6
AI IVP NT
treatment
ba
nd
 in
te
ns
it
BA 
**y
* 
*
Maternal cotyledons Day 150
0.1
0.2
0.3
0.4
AI IVP N
ba
nd
  i
nt
en
s
0
T
treatment
ity
*
 Maternal cotyledons Day 50
0
0.02
0.04
0.06
treatment
ba
nd
 in
te
0.08ns
it
0.1
AI IVP NT
y *
C D
C
E F
Maternal cotyledons Day 100
0.02
0.06
0.1
AI IVP NT
ba
nd
 in
te
ns
 
0
0.04
0.08
treatment
ity
   68
 
Hsp60 was detected in all samples of fetal and maternal cotyledons at different time 
points of 50, 100, and 150 days, by western blot analysis with polyclonal anti-Hsp60.  
Graphs of mean expression levels are presented in Figure 3.5.  Fetal cotyledons from 
day 150 (Figure 3.5C) showed no significant difference between IVP and NT 
compared to AI.  Hsp60 expression was significantly lower than control (AI) in IVP 
at day 50 (Figure 3.5A), and significantly higher than control (AI) in NT at day 100 
(Figure 3.5B).  Mixed results were also obtained for maternal cotyledons at the 3 time 
points.  At day 50 (Figure 3.5D), NT Hsp60 expression in maternal cotyledons was 
significantly higher than control (AI) and IVP.  No significant results were obtained 
for maternal cotyledons at day 100 (Figure 3.5E).  NT maternal cotyledons Hsp60 
expression was significantly lower than control (AI) at day 150 (Figure 3.5F). 
 
Further western blot analyses were conducted to determine if the significant results 
obtained with anti-Hsp60 were repeatable.  The same sample groups were used under 
the same conditions to keep variables constant.  After one repeat, the significant 
results obtained earlier were not repeatable, with the exception of maternal 
ween AI and NT.  cotyledons at day 150, which displayed significant results bet
However, compared to the initial blot where AI showed significantly higher Hsp60 
expression than NT (Figure 3.5F), the results were reversed with NT displaying 
significantly higher band densities than AI (Figure 3.7).  
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lanes 7-9: IVP Hsp60 and actin.  B lane 1: Hsp60 antigen, lane 2: IVP Hsp60 and 
60 kDa 
40 kDa 
 
     1      2       3       4      5      6      7        8       9 
A AI IVP 
Hsp60 
Actin 
60 kDa 
40 kDa 
    1      2      3      4      5       6      7      8       9     10 
B NT IVP 
Hsp60 
Actin 
 
Figure 3.6  Repeat western blot of maternal cotyledons at day 150. 
A lane 1: Hsp60 antigen (positive control).  Lanes 2-6: AI (control) Hsp60 and actin, 
actin, lanes 3-10: NT Hsp60 and actin.  20 µg of protein per lane was used. 
 
The results of maternal cotyledons at day 150 repeat western blot analysis (Figure 
3.6) are represented in a bar graph after a student t-test was implemented to determine 
a statistical difference between NT and AI (Figure 3.7). 
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Figure 3.7  Repeat western blot analysis of Hsp60 expression in maternal cotyledons 
at day 150. 
Hsp60 expression levels appeared to be significantly higher in the NT group of 
maternal cotyledons at day 150, compared to the control (AI) group when group 
verages were analysed with students t-test.  These results differed to the original 
s, where NT 
plementing visual inspections of the western blot x-ray scans, it appeared that 
 between x-ray films 
ay account for the inconsistent results.  Example 
comparisons between repeated western blots are presented in Figure 3.8. 
Hsp60 expression in matcots d150 
0.000
0.020
0.040
0.060
0.080
AI IVP NT
treatment
ba
nd
 in
te
ns
ity
* 
a
western blot analysis using the same samples under the same condition
was significantly lower than AI (Figure 3.5F).  p = 0.02, * p ≤ 0.05.  Bars represent 
standard error of the mean. 
 
By im
there were minimal differences in band density when comparing between the 
treatment groups on each individual blot.  As the Quantity One analysis software only 
compares samples on the same x-ray film, comparative analysis
of different western blots m
   71
 
 
Figure 3.8  Comparison between maternal cotyledon day 150 Hsp60 initial and 
much difference between control (AI) and treatments (IVP and NT), making any 
uantity One 
software. 
 
Initial Hsp60 western blot  Repeated Hsp60western blot  
 
 
repeated western blots.   
The same quantity of protein samples (20 µg) were used in the each lane for the 
repeated blot, with an Hsp60 positive control in each blot.  Visually, there is not 
differences in band densities susceptible to errors during analysis with Q
Hsp60 AI IVP
60 kDa 
H
Hsp60 AI IVP
sp60 NT IVP 
60 kDa 
Hsp60 NT IVP 
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.2.2 Hsp60 Western Blot Analysis (Trial 2 samples) 
P aternal cotyled
00, 150, were from Trial 1.  Protein samples which were extracted using TRizol 
were made available by Agresearch Ltd from a different trial (Trial 2) and using 
different time points with a treatment group of NT and AI as control.  To enable a 
thorough investigation of Hsp60 expression between treatment and control groups by 
determining that the prior obtained results were not specific to Trial 1 tissue samples, 
protein samples from Trial 2 were probed with Hsp60, again using SDS-PAGE and 
western blots.  Trial 2 proteins were from bovine placentomes, which differed from 
the protein samples of Trial 1 in that placentomes are the unseparated fetal and 
maternal cotyledon tissues still joined together, compared to Trial 1 fetal and 
maternal cotyledons, which are the separated components of the placentomes.  AI 
served as control, with NT being the treatment group.  No IVP samples were 
available from Trial 2.  Due to the samples originating from mixed time points, they 
n = 16), and days 154 – 163 (n = 9).  
gain, SDS-PAGE and western blot analysis was undertaken with polyclonal anti-
 
 
 
3
revious protein samples from fetal and m ons at time points of day 50, 
1
were grouped together into days 135 – 154 (
A
Hsp60.  The results of this investigation are presented in Figure 3.9. 
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lower than AI, p = 0.01.  B  AI (n = 4) and NT (n = 5) placentomes at days 135-163.  
In both groups Hsp60 expression is significantly higher in AI compared to NT.  This 
corresponds with maternal cotyledons at day 150 (Figure 3.5F) which had the same 
results at a similar time point (~ day 150). 
 
 
Figure 3.9  Hsp60 expression in AI and NT placentomes at time points of day 135-
163 of gestation, from Trial 2 proteins. 
A  AI (n = 6) and NT (n = 10) placentomes at days 135-154.  NT was significantly 
When group averages were analysed using students t-test, NT was significantly lower 
than AI, p = 0.03.  * p ≤ 0.05, ** p≤ 0.01.  Bars represent standard error of the mean. 
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.2.3 Hsp70 Western Blot Analysis 
eat shock proteins are associated with cellular response to stress.  They function to 
protect stressed cells as molecular chaperones by holding, translocating or refolding 
he earliest embryonic genes to be expressed, 
 
bserved in NT-derived blastocysts (Wrenzycki et al., 2005) and the heart, liver, 
spleen, lung, kidney and brain of cloned calves (Li et al., 2004)  
 
Having looked at mitochondria specific stress protein (Hsp60) with some level of 
increased expression, Hsp70 expression levels may indicate general cell stress with 
possible involvement in embryonic/fetal development disruption. 
 
Hsp70 proteins were detected with an anti-rabbit hsp70 polyclonal antiserum 
(Abcam, Cambridge, UK) in day 150 maternal cotyledons (Figure 3.10).  Incubation 
with the primary antibody was performed for 2 hours at a 1:200 dilution.  Goat anti-
rabbit IgG peroxidise-conjugated antibody (1:20,000, 1 hour) was used as a 
3
H
stress denatured proteins to prevent irreversible aggregation with other proteins in the 
cell (Oliveira et al., 2005).  Heat shock protein 70 (Hsp70) operates in the cell cytosol 
and is induced when the cell is stressed (Kawarsky & King, 2001).  Hsp70 is essential 
for activation of nuclear hormone receptors such as glucocorticoid and progesterone 
receptors, hormones which are vital for embryonic/fetal development.  Increased 
levels of Hsp70 have been shown to disrupt signalling effects on proteins involved in 
signalling pathways, resulting in cell growth arrest and developmental defects (Nollen 
& Morimoto, 2002).  Hsp70 is one of t
has been seen to be 15 times higher in bovine 2 cell IVP embryos compared to AI, 
and is recognised as having an important role in fetal development by regulating 
apoptosis (Jansen & Burton, 2004).  Altered Hsp70 transcription has also been
o
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ary  solution for 2 minutes the membrane was 
igure 3.10  Hsp70 western blot of maternal cotyledons at day 150. 
(treatment). 
 separated by SDS-
AGE (section 2.2.3) and blocked with 1.2 grams non-fat milk powder in 30 mls 
second antibody.  After addition of ECL
exposed on x-ray film for 20 seconds to give a strong signal.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AI IVP
IVP NT
F
20 µg of protein per lane.  Lanes 1-5: AI (control), lanes 6-9: IVP, lanes 10-17: NT 
 
20 µg of protein per sample of day 150 maternal cotyledons were
P
TBS-Tween overnight.  Proteins were transferred to nitrocellulose membrane (section 
2.2.4.1), prior to two hours primary incubation of anti-Hsp70 (1:200 dilution), and 2 
hours secondary incubation anti-rabbit IgG peroxidise-conjugated antibody (1:20,000 
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ons at day 150 was 
ignificantly higher in NT (treatment) placentomes compared to AI (control), p = 
.001.  Unfortunately further investigation into Hsp70 expression in bovine 
lacentomes was not able to be done due to unavailability of Hsp70 antibody. 
igure 3.11  Hsp70 expression in maternal cotyledons at day 150 of gestation 
I (n = 5), IVP (n = 4), and NT (n = 8) maternal cotyledons at day 150 of gestation.  
Hsp70 expression was significantly higher in NT (treatment) than AI (control), p = 
.001.  ** p ≤ 0.01.  Bars represent standard error of the mean. 
dilution).  Following students t-test, results were presented in a bar graph (Figure 
3.11) to show that Hsp70 expression in maternal cotyled
s
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 2.2.3) 
nd blocked overnight following protein transfer, prior to two hours incubation with 
nti-SOD2 
eroxidise-conjugated antibody (1:20,000 dilution). 
he only significant result was fetal cotyledons at day 150; SOD2 showed higher 
xpression in NT than AI, p = 0.002 (Figure 3.12). 
3.2.4 SOD2 Western Blot Analysis 
To check for oxidative stress, all six sample groups from Trial 1 protein blots were 
probed with SOD2 using the same western analysis method described in section 
2.2.4.  SOD2 is a mitochondria specific antioxidant metalloenzyme.  20 µg of protein 
per sample of day 150 fetal cotyledons were separated by SDS-PAGE (section
a
a (1:20,000 dilution), and 2 hours incubation with anti-rabbit IgG 
p
T
e
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Figure 3.12  SOD2 western blot of fetal cotyledons at day 150. 
20 µg of protein per lane.  Lanes 1-5: AI (n = 5), lanes 6-9: IVP (n = 3), lanes 10-17: 
NT (n = 8). 
 
When group averages were analysed using students t-test (Figure 3.13), SOD2 
expression was significantly higher in NT (treatment) than AI (control) placentomes, 
p = 0.002.  ** p ≤ 0.01.  However, when the samples from Figure 3.12 were analysed 
with another western blot under the same conditions with anti-SOD2, the results no 
longer showed any significant difference between the sample means. 
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igure 3.13  SOD2 expression in AI, IVP, and NT fetal cotyledons at day 150 
I (n = 5), IVP (n = 4), and NT (n = 8) fetal cotyledons at day 150.  NT was 
ignificantly higher than AI, p = 0.002.  ** p ≤ 0.01.  Bars represent standard error of 
e mean. 
t analyses of protein samples extracted from IVP embryonic tissue 
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3.2.5 Early Gestation Pre-Trial Investigation     
Western blo
ranging from day 20-31 of gestation were completed to determine if Hsp60 was 
present, and a students t-test identified any statistical significance (Figure 3.14A).  
The samples were divided into two groups; days 20-24 (embryonic tissue) and days 
26-31.  
   80
Figure 3.14  Hsp60 and SOD2 expression in early gestation embryonic protein 
0 expression in days 20-24 (n = 6) and days 26-31 (n = 8) of gestation.  Days 
20-24 Hsp60 expression was significantly higher than days 26-31, p = 0.006   
B  SOD2 expression in days 20-24 (n = 6) and day 26-31 (n = 8) of gestation.  Days 
20-24 SOD2 expression was 2 x higher than day 26-31, p = 0.01.  ** p ≤ 0.01.  Bars 
represent standard error of the mean. 
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and densities of the positive controls were 0.73 (AI day 150 fetal cotyledon) and 
 
e 
ternal 
B
0.56 (NT day 150 maternal cotyledon), which were low compared to the Hsp60 
expression of earlier gestational time points where the median band density was 1.8, 
with a maximum of 5.04 at day 20.  All early gestation samples were from either the 
whole embryo, or trophoblast tissue, as placentomes are not yet formed at this early 
stage. 
Results from incubating the same early gestation blot with anti-SOD2 were also 
significant (Figure 3.14B); day 20-24 SOD2 expression was 2 x higher than day 26-
31, p = 0.01.  Again, the positive controls were also considerably lower in relativ
band intensity; 0.71 (AI day 150 fetal cotyledon) and 0.66 (NT day 150 ma
cotyledon) compared to mean average of 1.8 and maximum at day 20 of 5.04.   
   82
Figure 3.15  Hsp60 western blot of early gestation embryonic protein samples. 
Lane 1: NT fetal cotyledon at day 150, lane 2: day 15 embryo, lane 3: day 18 embryo, 
lane 4: day 20 trophoblast, lane 5: day 20 trophoblast, lane 6: day 22 embryo, lane 7: 
day 22 trophoblast, lane 8, 9: day 24 trophoblast, lane 10: day 26 trophoblast, lane 11: 
NT maternal cotyledon day 150, lane 12: day 26 trophoblast, lane 13,14: day 29 
trophoblast, lane 15, 16: day 31 trophoblast, lane 17: day 27 trophoblast, lane 18: day 
29 trophoblast.  All samples were 20 µg of protein per lane, with the exception of 
lanes 4 and 5, which had 10 µg. 
 
Fetal AI and maternal NT cotyledons at day 150 of gestation were used as positive 
controls, based on previous Hsp60 positive results from western blot analyses (Figure 
3.15).  The positive control samples appeared to have considerably lower band 
densities (4 x) than the day 20-24 sample group.  Also, due to limited quantity of day 
20 samples, only 10 µg of protein was used per lane for the two day 20 samples, 
compared to 20 µg in all other lanes of the SDS-PAGE gel.  Therefore, results 
indicate that days 20-24 expression of Hsp60 was significantly higher than days 26-
31, p = 0.006.   
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otein quantity per lane match to lane descriptions in 
igure 3.15. 
e points of gestation, a result that validated the procedure of a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16  SOD2 western blot of early gestation embryonic protein samples. 
The membrane used for this western blot was the same that was used for Figure 3.15.  
All sample identification and pr
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Expression of SOD2 was also investigated by western blot analysis and students t-test 
using the same blot (Figure 3.14B), SOD2 showing significantly higher expression in 
days 20-24 than days 26-31, p = 0.01. 
The presence of Hsp60 in embryonic tissue at these gestational stages (days 20-31) 
suggests that detection of mitochondrial specific Hsp60 may be apparent in other 
early gestational tissues.  These results suggest that Hsp60 may be present at day 7 
and day 15 tim
Actin 
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roposed trial investigating the role of oxidative stress at gestational time points of 
ay 7 and day 15.  IVP embryos will be produced under control conditions and using 
aried levels of oxygen to provide stress treatment conditions on the developing 
mbryo up to day 7, which is the optimal time point to transfer to a bovine recipient 
onergan et al., 2006).  Day 15 embryos would also be investigated for indicators of 
tress at protein and mRNA levels, as most studies that use oxidative stress models 
nly use day 7 of gestation (likely due to convenience of not transferring to bovine 
cipients). 
ased on the significant results, which indicated high expression of stress proteins at 
round day 20 of gestation, it was decided to proceed with the proposed gestational 
ay 15 embryo trial; investigating the role of oxidative stress in vivo after IVP 
mbryonic stress treatment (see section B).     
OD2 significantly higher in NT than AI in maternal cotyledons at day 
50.  Hsp60 expression was significantly higher in NT than AI in two of the six blots 
 higher expression of stress proteins Hsp60 and 
p
d
v
e
(L
s
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re
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3.3 SUMMARY 
Hsp70 expression was significantly higher in NT than AI in fetal cotyledons at day 
150, as was S
1
probed (fetal cotyledons at day 100, and maternal cotyledons at day 50).  This 
suggests that there is significantly higher oxidative stress occurring in the NT groups 
than the AI groups, as indicated by the
Hsp70, and mitochondrial antioxidant SOD2.  Interestingly, the Trial 2 placentomes 
at around day 150 showed significantly higher expression of Hsp60 in the AI group 
compared to the NT.   
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After transfer onto a nitrocellulose membrane, it appears that major protein bands are 
17: NT. 
All placentome protein samples showed the presence of stress proteins (Hsp60, 
SOD2, and Hsp70) when analysed with western blots using appropriate antibodies.  
Significant differences of expression of these proteins were evident in many of the 
sample groups but unfortunately none of the results were repeatable.  Several 
explanations for these inconsistencies may be applicable.  Samples were frozen in 
only one aliquot that was thawed and frozen several times, resulting in possible 
protein degradation as displayed in Figure 3.17. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17  AI, IVP, and NT Fetal cotyledons at day 150 on Ponceau S stained 
nitrocellulose membrane, displaying possible protein degradation. 
missing, especially in lanes 1, 5, 8, 9, 10, and 11, which may be due to protein 
degradation.  The fetal cotyledons at day 150 aliquot had been thawed and frozen six 
times before the apparent degradation became obvious.  Lanes 1-4: AI, 5-9: IVP, 10-
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e same blot, to give a “normalised” measurement of each band for comparison 
etween sample grou when bands are not 
venly spaced or at odd angles, making it difficult to be exact when drawing the 
ctangle with the computer mouse around each band, including the possibility of 
issing a small portion of the band or including some of the neighbouring band. 
urther investigation would be required to repeat the western blot analysis on bovine 
I, IVP, and NT cotyledons which has already been completed, taking care to 
liminate or minimise the suggested possible errors that may be contributing to the 
nrepeatable results. 
Minimal differences between band densities were evident on scanned x-ray films 
prior to quantitation of band signal intensity.   Analysis using Bio-Rad Quantity One 
software enabled a comparison of band intensity, and therefore Hsp60 expression, 
between samples by measuring pixel density of an area specified. Each individual 
band is encompassed by a rectangle using the computer mouse, which is the area that 
has the pixel density measured.  Quantity One then adjusts the pixel density 
measurement by calculating in the background density and actin band densities from 
th
b ps from the same blot.  Error may occur 
e
re
m
 
F
A
e
u
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SECTION B 
arly 
estation samples (section 3.2.5) also suggest that stress proteins are expressed in 
to enable the investigation of the transcription of various stress 
proteins, it was decided that day 15 would be a suitable time point.  This decision was 
based on the quantity of embryos able to be produced and transferred at this time 
point and the approximate survival rate from previous studies (Farin et al., 2001). 
 
3.4 THE EFFECT OF OXIDATIVE STRESS ON EMBRYONIC 
DEVELOPMENT. 
 
The investigation into bovine AI, IVP, and NT placentomes provides evidence that 
stress proteins are expressed at time points of day 50, 100, and 150 of gestation 
(results section A).  In a study of bovine fetus development after treatment with 
varying oxygen levels during in vitro production of embryos by Fisher-Brown et al. 
(2005), it is suggested that free radicals due to oxidative stress may induce epigenetic 
effects that lead to abnormal placental growth.  Western blot analysis of IVP e
g
bovine embryos between days 20-31.  Levels of stress proteins appeared high at 
around days 20-24 of gestation, suggesting that significantly high levels of stress 
were operating at this point of gestation.  Due to the difficulty of producing sufficient 
numbers of embryos 
   88
Following the study of stress protein expression in bovine cloned placentomes, an 
vestigation into the effects of oxidative stress on embryonic development was 
undertaken.  Previous work has addressed blastocyst development and morphology at 
own et al., 2005, Harvey et al., 2004, Yuan et al., 2003).   
oor 
developmental results to blastocyst stage in the treatment groups (refer to Table 3.1) 
it was decided to cancel the 2% O2 group as there were not enough recipient cows to 
transfer the amount of blastocysts that would be required to successfully result in 
adequate day 15 conceptuses for experimental work.  During initial trial runs to 
blastocyst stage (Table 3.1) the 2% O2 group consistently produced lower numbers of 
in
day 7 of development, and also calf physical traits and placental morphology at 
parturition (Fisher-Br
 
This experiment will report on embryo development, morphology, and expression of 
stress proteins at day 7 and day 15 of development. 
 
3.4.1 Conditions Used to Generate In Vitro Produced Embryos  
Embryos were produced according to the standard operational procedure of the 
Agresearch Reproductive Technologies group.  60 – 80 ovaries were used per IVP 
run, depending on availability.  The usual level of oxygen (control) during the 
culturing of IVP embryos is 7%.  Due to this trial focussing on oxidative stress, the 
control group oxygen level was 7% from days 1-5, then 2% from days 5-7.  This was 
due to elimination of DNP (section 3.4.2) from day 5-7 culture media, as dropping 
the oxygen level to 2% at days 5-7 without DNP gave the same results as 7% O2 with 
DNP (Harvey et al., 2004).  Initial treatment groups of 2% and 20% O2 were based 
on previous studies of differing oxygen levels during IVP embryo production 
(Fischer-Brown et al., 2005, Harvey et al., 2004, Yuan et al., 2003) but due to p
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yo is 
ot able to activate the embryonic genome successfully, a typical halt in development 
3.4.2 2, 4-dinitrophenol and Oxidative Stress 
The standard oxygen level used in the laboratory for IVP embryos is 7% O2, 
therefore 7% O2 was chosen as the control group.  Due to the trial investigating 
oxidative stress, DNP was left out of the day 5-7 culture media.  DNP is an uncoupler 
of oxidative phosphorylation and can alter the activity of metabolic pathways by 
binding to protons in the intermembrane space of mitochondria, providing partial 
inhibition of mitochondrial ATP production by dissipating the proton gradient across 
the mitochondrial membrane.  The addition of DNP increases the demand on ATP 
production by glycolysis and mimics the inhibition of oxidative phosphorylation that 
occurs under reduced oxygen conditions in vivo, which aids in the development of 
morulae to blastocyst stage in the bovine (Harvey et al., 2004).  It is proposed DNP 
facilitates development by the stimulation of oxidative and glycolytic metabolism by 
increasing the uptake of pyruvate and glucose, while the partial inhibition of 
oxidative phosphorylation may reduce the level of intracellular reactive oxygen 
species (Rieger et al., 2002). 
blastocysts than the 20% O2 group (~ 4% lower on average), despite fertilization 
cleavage rates and numbers of 16 cell/morula embryos being similar across all 
groups.  It is at the 8-16 cell stage that the embryonic genome is activated and has to 
support itself rather than relying on maternal RNA derived from the oocyte (Jansen 
and Burton, 2004, Wrenzycki et al., 2005, Lonergan et al., 2006).  If the embr
n
called the “embryonic block” occurs. 
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cted by percoll toxicity.  The dilution of sperm 
with IVF media may have been incorrect.  HSOF wash may have been added to the 
sperm too fast during sperm preparation causing sperm to become shocked and 
damaged.  However, these possibilities were dismissed as sperm was observed to be 
capacitating during the standard sperm concentration count prior to fertilization.  
Capacitation is associated with removal of adherent seminal plasma proteins, 
reorganization of plasma membrane lipids and proteins, and changes in sperm 
homeostasis (Moseley et al., 2005).  These changes make the sperm “fertilization 
competent”, and are identified by sperm heads binding together.  Motility and sperm 
dilution also appeared normal when observed during check at fertilization. 
 
Following investigation of fertilization failure it was concluded that extra attention 
needed to be focused on the timing of fertilization.  If fertilization occurs later than 24 
hours after maturation, results are poor, due to the oocyte being blocked at metaphase 
2 of meiosis until sperm activation enables resumption and completion of meiosis.  If 
fertilization does not occur the oocyte reactivates itself anytime 30-32 hours after 
maturation and will cleave without sperm penetration to the 4-8 cell stage, where it 
arrests.  After careful attention to timing, the following run was back to the normal 
cleavage rate of 75%. 
3.4.3 IVP Fertilization 
Fertilization rates were relatively constant with the exception of one run that had only 
15% cleavage rate at the fertilization check on day 5.  Possible reasons for the poor 
fertilization results were investigated.  There may have been a problem with sperm 
preparation such as incorrect quantities of antioxidants added to the fertilization 
media.  The sperm may have been added to the percoll gradient too fast, causing it to 
mix with the gradient and become affe
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 Ovaries            Oocytes        Fertilization (%)  Day 7 blastocysts (%)
 
 
 
 
     
Run 1 60 339   
20% O2  112 85 (76) 13 (12) 
7 and 2% O2  113 76 (68) 29 (26) 
     
Run 2
2% O2  112 87 (78) 11 (10) 
 60 380   
2% O2  180 136 (76) 38 (21) 
7 and 2% O2  100 73 (73) 35 (35) 
     
20% O2  100 71 (71) 25 (25) 
Total Averages 60 359   
 
Table 3.1  Relationship between ovaries, oocytes, fertilization rate, and blastocyst 
ate between treatment groups (20% O2, 2% O2) and control group (7 and 2% O2). 
are split into respective treatment (20% O2, 2% O2) and control groups (7 and 2% 
20% O2  106 77 (73) 19 (18) 
2% O2  146 108 (74) 22 (15) 
7 and 2% O2  106 74 (70) 32 (30) 
r
The percentage figures from fertilization and blastocysts are based on the original 
number of oocytes.  The oocyte numbers originate from the group of 60 ovaries and 
O2). 
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.4.4 Oxidative Stress IVP Embryos 
ased on the results from Table 3.1, the following Trial was undertaken using the 
ethod of in vitro produced embryos as mentioned in section 2.2.1. 
nd 
roups a in vitro culture (24 hours post-fertilization).  Due to the higher 
of b astocyst yield fr e control group (based on results from Table 
l bers of blastocysts 
culated f m original oocyte number per group that gave rise cysts.  
ro  resulted in 67 cysts (15%) and the 7 and 2% O2 group had 
ixed grade blastocysts were transferred into 15 recipient heifers on day 7 of 
ent.  Results are represen  Table 3.2.  3 x 10 treatment e nd 7 x 
ry  were frozen in liquid nitrogen for later use. 
3
B
standard m
140 ovaries were aspirated to yield 937 COCs.  The fertilization rate was 75%, 
resulting in 703 presumptive zygotes, which were randomly split into treatment a
control g t 
expected rate l om th
3.1), the numbers allocated were weighted to 445 oocytes in the 20% O2 treatment 
group and 258 oocytes in the 7 and 2% O2 contro  group.  Num
were cal ro  to blasto
The 20% O2 g up blasto
107 blastocysts (41%), as per expected.  35 treatment mixed grade blastocysts and 33 
control m
developm ted in mbryos a
10 control emb os
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(%) 
bryos 
retrieved 
 
 Ovaries  Oocytes Fertilization 
(%) 
Day 7 
blastocysts 
Blastocysts 
transferred 
Day 15 
em
(%) 
Day 15  140 703     
trial   
20% 
O2 
 445 338 (76) 67 (15) 35 15 (43) 
7 and  258 206 (80) 105 (41) 33 15 (45) 
2% O2 
 
Table 3.2  Relationship between ovaries, oocytes, fertilization rate, and blastocyst 
before and after transfer.  
The percentage figures from fertilization and blastocysts are based on the original 
number of oocytes.  The oocyte numbers originate from the group of 140 ovaries and 
O2, n = 258).  The percentage of blastocysts retrieved are based on the original 
number of blastocysts that were transferred (20% O2, n = 35, 7 a
rate between treatment groups (20% O2, 2% O2) and control group (7 and 2% O2), 
are split into respective treatment (20% O2, n = 445) and control groups (7 and 2% 
nd 2% O2, n = 33) 
 
 
 
3.4.5 Blastocyst Production 
Visual differences were observed during the production of control and treatment 
embryos.  At the day 5 check and transfer to LSOF media the treatment embryo cell 
masses morphologically appeared much darker than the control embryos (Figure 
3.18). 
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d 
perivitilline space continue to appear larger on some of the treatment embryos (Figure 
3.19B).  Unfortunately zona pellucida and perivitilline space morphology was not 
taken into account during embryo production, it was only noticed during photography 
of sample embryos under higher magnification than used during embryo production.  
It would be interesting to observe differences of zona pellucida and perivitilline space 
morphology in any other study similar to this one.  It is at blastocyst stage (day 7) that 
the embryos were transferred into recipient heifers. 
 
Figure 3.18  Day 5 morula embryos from stress trial (200 x magnification). 
A  7 and 2% O2 (control) day 5 morula embryos.  B  20% O2 (treatment) day 5 
morula embryos.  Blastomeres are evident as they are beginning compaction into 
morulas. 
 
In Figure 3.18, the morula cells appear darker in treatment than control (A).  One of 
the treatment embryos (B) also has slightly a thicker zona pellucida.  Further into 
development, at day 7 blastocyst stage (Figure 3.19), the zona pellucida an
Zona pellucida A B 
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e inner cell mass.  The dashed line in B (control) shows a larger perivitilline space 
 
After 8 days in vivo, the day 15 embryos were removed from the recipient heifers.  
The uterine tracts were retrieved at the abbatoir and labelled in order of slaughter.  
The tracts were placed in plastic bags and transported back to the sorting facilities at 
AgResearch where the concepti were flushed from the uterine tracts with room 
temperature sterile saline solution (0.9% w/v).  Survival of concepti (Table 3.2) and 
measurements of embryo length were recorded (Figure 3.23).  Embryo survival was 
similar between control and treatment groups, with 43% of the treatment group, and 
45% of the control embryos, surviving to day 15 after transfer. 
A B 
 
Perivitilline 
space Inner cell 
mass 
Inner cell 
mass 
Figure 3.19  Day 7 blastocysts from oxidative stress trial (200 x magnification) 
A  20% O2 day 7 blastocysts.  B  7 and 2% O2 day 7 blastocysts.  Solid arrows show 
th
between the zona pellucida and trophectoderm than in A (treatment). 
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3.5 OXIDATIVE STRESS DAY 15 EMBRYOS 
 
Photographs were taken immediately after embryo retrieval to determine any 
morphological differences between the treatment and control groups, as shown in 
Figures 3.20, 3.21, and 3.22.  Embryo lengths were also recorded, with average 
measurements for each group presented in Figure 3.23. 
 
 
 
 
Figure 3.20  Photographs of day 15 control (7 and 2% O2) and treatment (20% O2) 
embryonic disc (Figure 3.22). 
 
Day 15 7 and 2% Day 15 20% 
 
 
embryos after retrieval from recipient heifers. 
Photographs were taken in 90mm Petri dishes, under normal lighting conditions 
without magnification.  At day 15, embryos appear “stocking-like”, with an 
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igure 3.21 presents a distinct morphological difference between the treatment (A) 
e interfered with normal embryonic 
ult to detect rather than absent.  Figure 3.22 depicts a 
normal representation of an embryonic disc. 
 
 
 
 
A B 
 
 
Figure 3.21  Day 15 embryos from 20% O2 treatment group (100 x magnification). 
A  Day 15 20% O2 treatment embryo.  The arrow notes unusual “furry” growths on 
the trophoblast exterior of the embryo. 
B  A relatively normal looking day 15, 7 and 2% O2 control embryo.   
 
F
and control (B) day 15 embryos.  It is not usual to see growths on the trophoblast 
exterior, suggesting the treatment may hav
development.  Embryonic discs were not visible in all embryos, however it is possible 
that they may have been diffic
   98
 
 
 
 
 
 
 
 
ill form.  This is a good example of normal 
 
Embryonic 
disc  
 
Figure 3.22  Day 15 embryo from control group (200 x magnification). 
The solid arrow notes an embryonic disc surrounded by the trophoblast on a control 
group embryo, from which the fetus w
embryonic development. 
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reatment and 
, n = 8) groups (Figure 3.23).  Morphologically, treatment 
embryos appeared noticeably wider than control embryos.  However measurements 
were not taken due to the fragility of the embryos.  Bars represent standard error of 
the mean. 
 
 
Figure 3.23  Comparison between average embryo lengths of day 15 t
control embryos. 
The average concepti length differed by 0.6cm between treatment (20% O2, n = 10) 
and control (7 and 2% O2
Comparison between average day 15 embryo lengths 
in treatment and control groups
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.6 PROTEIN AND RNA EXTRACTION FROM TRIAL EMBRYOS 
Day 15 embryos were processed with TRIzol to extract protein and RNA, each 
sam
ith 
 
3.6.1 
 
crylamide gel and transferred to a nitrocellulose membrane for 2 hours.  The 
sulting ponceau S stain indicated minimal protein present (Figure 3.24).  This was 
onfirmed with an unsuccessful antibody probe (anti-hsp60), which resulted in no 
ignal at all.  Based on methods by Lequarre et al. (2001), it was decided that groups 
f 50 blastocysts would be necessary to use for immunodetection.  Five groups each 
f treatment and control embryos were produced and stored at -20°C for later use. 
3
 
ple was a single embryo.  Due to such low tissue amounts day 7 blastocysts were 
processed at 10 blastocysts per sample using the method provided by Dr Craig Sm
(section 2.2.2.2). 
Day 7 Protein and RNA Extraction 
Day 7 protein samples were in 10 µl aliquots which had 5 µl 3x Laemmli buffer
added and boiled for 5 minutes at 95°C.  The samples were then run on a 12.5% 
a
re
c
s
o
o
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12-20: 20% O2 treatment group.  Only a single dominant protein band was 
 
ies 
this band present at ~ 70 kDa.   
 
Harvey et al. (2007) extracted RNA from pools of bovine blastocysts (50 x 
blastocysts per pool) to obtain clear experimental results, therefore this appeared to be 
a more appropriate number of blastocysts to use per sample.  Ten pools each of 50 x 
day 7 IVP blastocysts were created; five pools of the treatment and five of control 
(total of 500 blastocysts).  The standard TRIzol method of RNA and protein 
extraction was used (2.2.2.4).  Due to the minimal amount of RNA extracted (1 µg) 
samples were not run on a gel to verify RNA integrity, NanoDrop was used to 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24  Ponceau S stained nitrocellulose membrane of day 7 trial samples. 
Lanes 1-10: 7 and 2% O2 control group.  Lane 11: molecular weight marker.  Lane 
transferred from 2 SDS-PAGE gels from each pool of 10 blastocysts per sample. 
Each lane contained the complete amount of protein extracted from the 10 blastocysts 
per sample, in 10µl of 1% (w/v) SDS solution.  Molecular weight marker identif
75 kDa 
50 kDa  
25 kDa 
 
   1   2    3   4    5    6   7    8   9  10 
 11  12 13 14 15 16  17 18  19 20 
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entify successf  
erified using a coomassie blue stained SDS-PAGE gel and a ponceau S stained 
itrocellulose membrane stained.  Both the stained gel and membrane displayed no 
rotein bands.  After careful analysis of the extraction procedure it was realised that 
e guanidine-HCL wash solution used contained no ethanol, therefore precipitation 
id not occur and the protein was discarded with the guanidine-HCL solution. 
 repeat production of IVP embryos with control and treatment groups resulted in 5 
amples of 50 x treatment embryos and 4 samples of 50 x control embryos.  Protein 
nd RNA was extracted successfully (verified with NanoDrop) using the standard 
RIzol method (section 2.2.2.4).  Each sample contained proteins from 50 embryos in 
dded 
u S (Figure 3.25). 
id ul extraction.  Unfortunately no protein was present.  This was
v
n
p
th
d
 
A
s
a
T
minimal volume of HEPES buffered TCM, which had 5 µl 3x laemmli buffer a
and boiled for 5 minutes at 95°C prior to separation by SDS-PAGE using a 12.5% 
acrylamide gel.  Samples contained the full amount of protein that was extracted in 20 
µl 1% SDS, combined with 10 µl 3 x Laemmli, equated to a total volume of 30 µl.  
The separated proteins were transferred to a nitrocellulose membrane for two hours at 
50 volts and stained with poncea
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Lanes 1-9: Protein from pools of 50 x day 7 embryos per lane.  Lanes 1-4: control (7 
supersensitive measure of Hsp60 
protein presence.  1.5 ml of luminol/enhancer solution was combined with 1.5 ml 
stable peroxide solution and added to the nitrocellulose membrane for 5 minutues 
before the light signal was detected after exposure of the membrane for 4 minutes on 
x-ray film.   Hsp60 displayed a positive signal in all lanes (Figure 3.26).  However, 
lanes 4 and 9 had a very weak signal.  Unfortunately, anti-actin did not show a strong 
signal in any sample except the positive control after incubation for 2 hours at room 
temperature (Figure 3.27), suggesting that there may not be much actin present in day 
7 embryos. 
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75 kDa 
50 kDa 
25 kDa 
 
 
 
Figure 3.25  Ponceau S stained nitrocellulose membrane of day 7 treatment and 
control embryos. 
and 2% O2).  Lanes 5-9: treatment (20% O2).  Lane 10: Hsp60 positive control, IVP 
fetal cotyledons at day 150, 20 µg protein. 
 
Overnight incubation at 4°C of the nitrocellulose membrane with anti-Hsp60, 
confirmed immunoreactivty with the Hsp60 positive control sample but no signal was 
apparent for the day 7 blastocysts.  SuperSignal®West Femto Maximum Sensitivity 
Substrate Kit (section 2.1.7) was employed as a 
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Figure 3.26  Hsp60 western blot of day 7 blastocysts, control and treatment groups. 
ane 1: positive control IVP fetal cotyledons at day 150, 20 µg protein.  Lanes 2-6: 
20% treatment group.  Lanes 7-10:  7 and 2% control group. 
 
60 kDa 
 1       2         3          4          5        6       7        8        9        10 
L
20% O2 treatment group.  Lanes 7-10:  7 and 2% O2 control group. 
 
 
40 kDa 
 
Figure 3.27  Actin western blot of day 7 blastocysts, control and treatment groups. 
Lane 1: positive control IVP fetal cotyledons at day 150, 20 µg protein.  Lanes 2-6: 
 
To determine whether there was a significant difference between the day 7 control 
and treatment groups, normalisation with actin using the Quantity One programme 
was necessary.  As there was no signal from the actin immunodetection, a graph 
displaying the various band intensity differences between sample groups gives some 
indication of the differences between control and treatment groups (Figure 3.28), 
based on the assumption that there are equivalent amounts of protein in each sample. 
 1          2           3          4          5         6         7          8         9        10 
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.  20 µg protein.  
anes 2-6: 20% O2 treatment group, day 7 blastocysts.  Lanes 7-10: 7 and 2% O2 
control group, day 7 blastocysts.  Lanes 2-10 contained all protein extracted from 
pools of 50 blastocysts per sample. 
 
Figure 3.28  Comparison between treatment (20% O2) and control (7 and 2% O2)
day 7 blastocysts. 
Lane 1: positive control; fetal cotyledon day 150 of gestation, IVP
L
Hsp60 day 7 treatment and control embryos
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Hsp60, cyclo-oxygenase 2 (COX2), Triosephosphate isomerise (TIM), and SOD2 
were expression was investigated at protein level.  Hsp70 and glucose transporter 1 
(GLUT1) expression was investigated at mRNA level.  The purpose of the 
investigation was to determine if oxidative stress was affecting expression levels of 
proteins and genes associated with stress, metabolism, and development. 
 
3.7.1 Hsp60 Expression in Day 15 Embryo Samples 
Anti-hsp60 (Stressgen, Victoria, Canada) was used for detection in Western blot 
analysis as described in section 2.2.4, using 1:10,000 dilution for the primary 
antibody, and 1:20,000 dilution for the secondary antibody (goat anti-rabbit)  There 
was no statistical difference in Hsp60 expression between treatment and control 
groups as judged by band density differences when normalised with actin (Figure 
3.29).  Band density averages were similar; 0.40 for treatment and 0.41 for control 
(Figure 3.30). 
3.7 INVESTIGATION OF PROTEIN AND mRNA EXPRESSION 
ASSOCIATED WITH OXIDATIVE STRESS 
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p.  Lanes 11-18: 7 and 2% O2 control group.  10 
g protein per lane. 
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Figure 3.29  Day 15 western blot comparing Hsp60 expression between control and 
treatment groups. 
Lanes 1-10: 20% O2 treatment grou
  11   12   13    14  15    16    17    18 
µ
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Minimal differences were observed in average band intensities in Hsp60 expression 
gation of oxidative stress, the day 15 embryo blot was probed with 
COX2.  COX2 converts arachidonic acid to prostaglandin, and is essential for 
blastocyst implantation (Lim et al., 1999).  Prostaglandins participate in a variety of 
cellular functions including cell proliferation and differentiation.  Probing with anti-
COX2 primary antibody at a dilution of 1:2000 for 2 hours and a secondary antibody, 
sheep anti-mouse (1:10,000) for 2 hours gave a good chemiluminescent signal after 4 
minutes of exposure to the membrane.  The results after normalisation with actin 
were not significantly different between the control and treatment groups (Figure 
3.32).  
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Figure 3.30  Comparison between treatment (20% O2) and control (7 and 2% O2). 
between treatment (0.40) and control (0.41) groups.  20% O2 n = 10, 7 and 2% O2 n 
= 8.  Bars represent standard error of the mean. 
 
 
3.7.2 COX 2 Expression in Day 15 Embryo Samples 
Due to investi
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15 western blot comparing COX2 expression between control and 
eight marker.  Lane 2: positive control; day 18 embryo, AI, 10 
µg protein.  Lanes 3-12: 20% O2 treatment group.  Lanes 13-19: 7 and 2% O2 control 
group.  10 µg protein per lane. 
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Figure 3.31  Day 
treatment groups. 
Lane 1: molecular w
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Figure 3.32
 day 15 embryos. 
Minimal differences were observed in average band intensities in COX2 expression 
etween treatment (1.85) and control (1.81) groups.  20% O2 n = 10, 7 and 2% O2 n 
 8.  Bars represent standard error of the mean. 
 TIM expression in Day 15 Embryo Samples 
tic enzyme that plays an important role in several metabolic 
t energy production.  Larger than normal 
 glucose are required during oxidative stress, so probing the day 15 blot 
) may indicate whether more of this 
iluminent signal after 4 minutes exposure to the membrane 
3).  After normalisation with actin using Quantity One, there were no 
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  Comparison of COX2 average expression between treatment (20% O2) 
and control (7 and 2% O2)
b
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3.7.3
TIM is a glycoly
pathways and is essential for efficien
quantities of
with TIM antibody (Santa Cruz Biotechnology
enzyme is transcribed in the treatment group or not.  Incubation with the primary 
antibody was overnight at 4°C at a dilution of 1:500.  Rabbit anti-goat IgG bound to 
the secondary antibody, with an incubation of 2 hours at a dilution of 1:10,000.  The 
results were a good chem
(Figure 3.3
significant differences between control and treatment groups (Figure 3.34). 
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igure 3.33  Day 15 western blot comparing TIM expression between control and 
eatment groups. 
Lanes 1-10: 20% O2 (treatment).  Lane 11: molecular weight marker, displaying 
eights of 75, 50, 37, and 25 kDa.  Lanes 12-19: 7 and 2% O2 (control).  10 µg 
rotein per lane. 
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Figure 3.34 2) 
Minima
between treatm n 
 
3.7.4 SOD2 Expression in Day 15 Embryo Samples 
Continuing to check proteins related to oxidative stress, the day 15 nitrocellulose 
membrane was subjected to western blot analysis with anti-SOD2.  The primary 
antibody was incubated at a dilution of 1:20,000 for 2 hours, followed by goat anti-
rabbit (1:20,000) for 2 hours.  The results after normalisation with actin gave a strong 
chemiluminescent signal after 1 minute of exposure to the membrane (Figure 3.35), 
with a significant result of p = 0.009.  After normalisation with actin using Quantity 
One, the average expression of SOD2 was approximately 2 times higher in the 
control group than the treatment group (Figure 3.36). 
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  Comparison of TIM average expression between treatment (20% O
and control (7 and 2% O2) day 15 embryos. 
l differences were observed in average band intensities in TIM expression 
ent (0.27) and control (0.20) groups.  20% O2 n = 10, 7 and 2% O2 
= 8.  Bars represent standard error of the mean. 
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 SOD2 expression between control and 
previous blots.  
ignal obtained after one minute of exposure to x-ray film.  10 µg protein per lane. 
 
 
 
 
 
 
 
Figure 3.35  Day 15 western blot comparing
treatment groups. 
Lanes 1-10: 20% O2 (treatment).  Lanes 11-18: 7 and 2% O2 (control).  Molecular 
weight markers at 40 and 30 kDa bands are based on reference to 
S
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igur
eatment (20% O2) and control (7 and 2% O2) groups.   
The control group (n = 8) showed significantly higher SOD2 expression relative to 
e treatment group (n = 10).  p = 0.009.  Bars represent standard error of the mean. 
.8 RT-PCR ANALYSIS 
 typical mammalian cell contains about 80-85% of ribosomal RNA, made up of 
ubunits: 28S, 18S, and 5S (Maniatis et al., 1982). 
uality of extracted mRNA from day 15 embryos was checked by running them 
rough a 1.2% Agarose RNA gel (section 2.1.4) at 6-7 V/cm after samples were 
enaturated at 65°C for 15 minutes and chilled for 5 minutes.  Clear 28S and 18S 
ands were visible, indicating that the mRNA was stable and intact after extraction 
om embryonic tissue (Figure 3.37). 
 RNA was carried out as described in section 2.2.5.1, which 
atures and times are as mentioned in section 2.2.5.2, and were 
followed for all genes.  
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RT of the day 15
provided cDNA transcripts for PCR amplification of selected genes.  Denaturing and 
annealing temper
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 confirm the integrity of the RNA.  1 
g of Day 15 embryo RNA was used per lane.  Lanes 1-6: day 15 control RNA.  
Lanes 7-12: day 15 treatment RNA. 
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Figure 3.37  1.2% Agarose RNA Gel providing verification of Day 15 embryo RNA 
integrity. 
The distinct 28s and 18s RNA bands in all lanes
µ
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.8.1 GLUT1 
LUT
een associated with a decrease in oxygen concentration in post-compaction bovine 
P embryos compared to in vivo (Harvey et al., 2004).   
mplification of PCR mixture with GLUT1 forward and reverse primers (1.25 µl of 
ach per sample) where each cycle included denaturation at 94°C for 30 seconds, 
annealing primers to target sequences for 30 seconds, primer extension at 72°C for 
0 seconds, was carried out for 30 cycles.  After mixing 2 µl of 6x DNA gel loading 
ye with the 12 µl PCR product, a 100bp marker and 5 µl samples were run on a 7% 
crylamide TBS gel at 20V/gel.  PCR products identity were detected by ethidium 
romide staining and ultraviolet light visualisation, using a BIO-RAD Gel Doc 1000 
aging densitometer.  The image resulted in a very bright signal so it was decided to 
peat the procedure with another PCR amplification of GLUT1, this time using only 
0 cycles to see if a difference between samples could be detected.  There was a 
isible difference but it seemed to be between samples rather than treatment and 
ontrol groups. 
 
e 
riginal RT product.  The dilution was centrifuged briefly and vortexed to ensure 
orough mixing before pipetting.  The Hsp70 PCR was run at the same cycle as 
entioned for GLUT1, for 20 cycles.  Following ethidium bromide staining of the 
gel, the samples were run on and image processing it appeared that several of the 
3
G 1 is a glucose transporter.  Significantly increased transcription of GLUT1 has 
b
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3.8.2 Hsp70 
An initial trial of RT-PCR using Hsp70 primers resulted in a very strong signal, so a 
repeat PCR amplification was carried out using a 1 µl sample of a 1:10 dilution of th
o
th
m
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mbryo samples did not appear to express Hsp70.  This is unusual as Hsp70 is known 
 be largely expressed in early embryonic development.  To investigate whether 
ere may have been a problem with the RT sample dilution, the Hsp70 PCR was 
peated using 0.5 µl of the original sample product instead of the 1:10 sample 
ilution.  Results showed that Hsp70 was expressed in all embryo samples (Figure 
.28).  Differences in signal could be seen between samples but not between 
eatment and control groups. 
bromide stained 7% acrylamide 
100bp ladder.  Lane 2: RT-negative control sample.  Lanes 3-15: 20% O2 treatment 
e
to
th
re
d
3
tr
 
 
 
Figure 3.38  Hsp70 gene expression on an ethidium 
TBS gel 
After 20 cycles expression of Hsp70 was evident in all day 15 samples.  Lane 1: 
samples.  Lanes 16-25: 7 and 2% O2 control samples.   
1   2    3    4   5   6     7   8    9   10  11 12  13 14  15 16 17 18  19  20  21 22 23 24 25 
                                     Treatment                                                   Control 
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.9 SUMMARY 
orphologically, at day 5 the treatment embryos (20% O2) appeared darker in 
ppearance (Figure 3.18).  This darker appearance may be due to larger numbers of 
pid droplets that is typical of IVP embryos, compared to in vivo-derived embryos 
be et al., 1999).  It has been previously noted that embryos from high oxygen 
oncentrations (20%) appear darker than those produce in less oxygen, due to 
xidative stress increasing the formation of free oxygen radicals that may oxidise 
creased levels of fatty acids, which results in embryos with a dark appearance and 
ss viability (Fischer-Brown et al., 2005).   
n the control embryos (Figure 3.18).  It is usual for the zona pellucida to be 
g embryos.  At day 7 the treatment embryos had 
a larger perivitilline space compared to control, which is also associated with in vivo-
derived embryos (Abe et al., 1999). 
 
Similar numbers of embryos survived transfer to day 15 from both the treatment and 
control groups; 43% for treatment and 45% for control.  Morphologically at day 15 
the treatment embryos were slightly shorter and wider compared to control.  One 
treatment embryo had strange villious growths projecting from the trophectoderm, 
one may speculate the possibility of interference with placental growth further into 
development. 
3
M
a
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c
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At day 5 the zona pellucida (ZP) in one of the treatment embryos was noticeably 
thicker tha
thinner in IVP embryos, with a thick ZP usual for in vivo derived embryos, which is 
associated with integrity of developin
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 Hsp60 were all present at protein level, although the 
en levels of oxidative free 
dicals may be higher in the treatment embryos due to higher oxygen and oxidative 
COX2, TIM, SOD2, and
differences were insignificant, with the exception of SOD2 which had 1.5 x the 
expression levels in the control group compared to the treatment group (Figure 2.23), 
suggesting less mitochondrial antioxidant protection wh
ra
stress. 
 
At the mRNA level, GLUT1 and Hsp70 expression was evident.  On visual 
inspection there appeared to be no differences between treatment and control groups 
but there did seem to be differences between samples. 
 
   120
CHAPTER 4: DISCUSSION 
within basic research and the biomedical sector; 
pplication possibilities are theoretically limitless.  The next step may be to 
implement cloning in the agricultural production system; however cloned animal 
ounterparts.  One suggestion for this phenomenon is that incomplete nuclear 
programming leads to epigenetic errors and incorrect genomic imprinting.  
ns to the electron transport chain.  This in turn may result in high levels of 
 signalling processes, leading 
to aberrant gene transcription.  Significantly higher expression levels of stress 
proteins, Hsp60, Hsp70, and SOD2, in NT embryos compared to IVP and AI would 
suggest that there may be some substance to this hypothesis. 
 
4.1      EXPRESSION OF MITOCHONDRIAL STRESS PROTEINS IN 
BOVINE COTYLEDONS 
 
Although the technology of nuclear transfer cloning still has relatively low success 
rates, cloning is used both 
a
welfare and a higher efficiency of viable offspring require improvement to secure the 
application of cloned animals.  One major developmental anomaly of cloned cattle 
that is linked to an unacceptably high level of losses during pregnancy is placental 
abnormality.  Bovine cloned embryos have fewer and larger placentomes than in vivo 
c
re
Mitochondrial DNA may suffer mutations which alter protein transcription, causing 
disruptio
reactive oxygen species, inappropriate cell death via apoptosis, or transcription of 
mitochondrial stress proteins which can disrupt cellular
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oyed to determine if there was any differences in expression 
P, and AI fetal and maternal cotyledons 
t time points of day 50; at the start of placentome formation, day 100; when the 
.  After repeating the analysis under the same 
xperimental conditions, previous significant differences were not reproducible.  One 
t after diluting brain protein samples in Laemmli buffer and denaturing 
at 95°C for 5 minutes before freezing and storing at -80°C, that after several 
freeze/thaw cycles immunoreactivity of target proteins was strongly reduced.  The 
Protein studies were empl
between the treatment (NT) and control (AI) bovine cotyledon groups.  NT embryos 
were in vitro produced.  IVP cotyledon protein samples were available for use and, 
hence included as an interesting comparison.  NT embryos are grown in identical 
culture conditions to IVP embryos, therefore including an IVP sample group would 
eliminate explanations of any results that may be attributed to culture conditions. 
 
4.1.1 Hsp60 Protein Analysis 
Hsp60 was detected in all samples of NT, IV
a
placentomes were completely formed, and day 150; when hydrallantois frequently 
occurs.  Hydrallantois is an excessive accumulation of allantoic fluid which may be a 
consequence of placental dysfunction (Wells et al., 1999).  High expression of Hsp60 
was observed in NT fetal cotyledons at day 100, NT maternal cotyledons at day 50, 
and significantly lower expression in NT cotyledons at day 150.  Results were based 
on comparisons with AI cotyledons
e
possibility is that the protein samples degraded with repeated freezing and thawing, 
which was demonstrated to occur in Figure 3.15.  A study on the ability of proteins in 
frog tissue to stay unchanged after freeze/thaw procedure showed that proteins which 
kept their structure were only 36% of the amount detected in controls, with results 
differing between frog tissues (Woods et al., 2006).  Grange-Midroit et al. (2002) 
discovered tha
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different protein samples from placentome tissues at day 150 were 
vestigated, NT displayed significantly lower Hsp60 expression than AI at time 
Despite the inconsistent results, it is clear that Hsp60 is present and that there may be 
significant differences between the NT and AI groups.   
 
4.1.2 Hsp70 Protein Analysis 
Examination of Hsp70 at protein level in day 150 maternal cotyledons showed that 
Hsp70 expression was significantly higher in the NT group compared to AI.  A large 
body of evidence now suggests a correlation between oxidative stress and heat shock 
protein induction (Calabrese et al., 2003, Calabrese et al., 2005, Jansen and Burton, 
2004, Kawarsky and King, 2001, Lin et al., 1998, Nollen and Morimoto, 2002).  With 
the availability of transgenic animals and gene transfer, it has become possible to 
over express the gene encoding Hsp70 to show that Hsp70 proteins protect cells from 
injury, it has been demonstrated that overproduction of Hsp70 leads to protection in 
several different models of nervous system injury (Kelly et al., 2002, Yenari, 2002).  
It is recognised that Hsp70 has an important role in regulating apoptosis by 
proteins used in this study were prepared in the same manner, and also seemed to 
change in immunoreactivity after freeze/thaw cycles.  One may therefore speculate 
that protein degradation due to repeated freeze/thaw cycles may be an explanation as 
to why significant differences in protein expression were not repeatable. 
 
When 
in
points of days 135-154 and days 154-163 of gestation.  Note these were protein 
samples were from placentome tissues, not cotyledons as previously investigated; 
hence a direct comparison cannot be made. 
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suppressing apoptotic signals after et al., 
2005).  The results in this study would suggest that NT cotyledon cells are responding 
dria. 
mitochondrial disruption (Stankiewicz 
to a higher level of stress than AI cotyledons, possibly due to oxidative stress as a 
result of inefficient mitochon
 
4.1.3 SOD2 Protein Analysis 
Mitochondria specific stress protein, SOD2, was expressed significantly higher in NT 
fetal cotyledons than AI at day 150.  Other studies of SOD2 have indicated 
conflicting results; Harvey et al. (1995) concluded that no SOD2 mRNAs were found 
in bovine blastocysts, however they were detected in mouse embryos at all stages.  
Lequarré et al. (2001) found no expression in bovine embryos of SOD2 at 9-16 cell 
and morula stages, but it was present at zygote, 5-8 cell, and blastocyst stages.  
Others have found SOD2 to be present at all developmental stages up to blastocyst 
(Rizos et al., 2003, Gutiérrez-Adán et al., 2004), and implicate oxidative stress and 
ROS as a probable cause of increased SOD2 transcription.  Samper et al. (2003) state 
that endogenous oxidative stress in murine results in nuclear genomic instability, 
which may influence cell growth and embryonic lethality.  This study suggests there 
is mitochondrial oxidative stress in NT cotyledons based on high expression of the 
mitochondrial stress protein marker, SOD2. 
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dies 
omparing the morphology of bovine IVP and in vivo embryos have observed a much 
, gra P blastocysts, which has been attributed to the 
4.2 OXIDATIVE STRESS TRIAL 
 
4.2.1 Embryo Morphology at Blastocyst Stage 
Morphological differences were observed between control and treatment embryos at 
both morula and blastocyst stages.  Morula treatment embryos appeared darker, and 
displayed a darker cytoplasm at blastocyst than control embryos.  Several stu
c
darker iny appearance in the IV
presence of lipid droplets (Abe et al., 1999, Farin et al., 2001, Lonergan et al., 2006).  
Both treatment and control embryos were IVP, however these morphological reports 
appear exaggerated in the treatment embryos, suggesting the cause of the dark 
appearance is extended further.  Abe et al. (1999) found that IVP morula and 
blastocyst stage embryos with darker cells possessed many lipid droplets, vesicles 
resembling lysosomes, and fewer cellular organelles such as mitochondria, compared 
to in vivo embryos.  Farin et al. (2001) suggest that the increase in lipid present in 
IVP embryos is due to lipid accumulation resulting from inefficient metabolism of 
lipid by embryonal mitochondria.  The authors also note that during development 
from compact morula to blastocyst stage the cellular volume occupied by 
mitochondria doubled for the in vivo produced embryos, compared to IVP.  It has also 
been suggested that increased lipid content of IVP embryos may result from 
insufficient metabolism by mitochondria, which is consistent with the observed 
reduction in volume density of total mitochondria in IVP embryos compared to in 
vivo (Rizos et al., 2003).  Thompson (2000) states that the role of intracellular lipid in 
mitochondrial ATP production is still unresolved within the production of bovine 
embryos. 
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velopmental 
ysfunction.  However, no difference in expression of the mitochondrial stress 
and the absence of the zona pellucida is 
nown to cause dispersion of the blastomeres.  It has been shown that the zona 
during production one would 
ssume the control embryos to display a thicker zona pellucida compared to the 
 this study. 
 
Using this information to explain the darker appearance of treatment embryos 
compared to control, one may assume that treatment embryos have comparably more 
metabolically compromised mitochondria, which may lead to further de
d
marker, Hsp60, was observed between the control and treatment groups.  
 
It was interesting to note the observation that at least one treatment embryo had a 
noticeably thicker zona pellucida (refer to Figure 3.18).  The zona pellucida maintains 
the integrity of early developing embryos 
k
pellucida is thinner in IVP embryos compared to in vivo (Abe et al., 1999), therefore 
considering that the treatment group had higher stresses 
a
control group, which did not occur in
 
The perivitilline space in the control embryos was noticeably larger than the 
treatment embryos at the day 7 blastocyst stage in at least one instance.  IVP embryos 
are known to have a narrower perivitilline space compared to in vivo (Abe et al., 
1999, Van Soom and de Kruif, 1992) and stressed embryos have been shown to 
contain higher levels of cell fragments and debris such as lipid droplets (Abe et al., 
1999).  Therefore, based on the assumption that the treatment embryos were at a more 
compromised state than the control IVP embryos, it may be presumed that the 
perivitilline space should be larger in the control group; which was indeed the case in 
this study. 
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le.  Most losses occur by day 14-15, or within a 
eek after transfer (Farin et al., 2001), however it would be of interest to observe 
mpromised at around day 50 when placentome 
unusual growths from the trophoblast 
exterior (Figure 3.21A).  Although treatment embryos appeared relatively unaffected 
at this stage compared to control, this morphological abnormality may be an 
indication of pathology that will compromise embryo viability further into 
development.  Yuan et al. (2003), in a study using 20% oxygen during IVP of bovine 
embryos to blastocyst stage state that the increased ROS levels in embryos cultured 
under 20% oxygen are probably implicated in retarded embryonic growth.  Altered 
 
4.2.2 Embryo Survival at Day 15 
Day 15 was chosen as a time point due to logistical reasons, to transfer as many 
embryos into recipients as possib
w
whether treatment embryos were co
formation begins (Lee et al., 2004). 
 
Embryo survival at day 15 after transfer was similar between control and treatment 
groups; control: 45%, treatment: 43%.  Pregnancy rates following transfer of embryos 
produced in a variety of culture systems range from about 45% to 75% (Farin et al., 
2001), therefore these results were within the expected range.  The minimal 
difference between control and treatment groups may suggest that if embryos 
survived to blastocyst stage they appeared relatively unaffected by treatment at day 
15, possibly due to optimal in vivo conditions rather than different IVP culture 
systems.   
 
4.2.3 Embryo Morphology at Day 15 
One of the treatment embryos displayed 
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mtDNA mutations may be a causative 
ctor behind this unusual trophoblast growth. 
stress in the treatment group of this study, apoptosis could be expected to 
gene expression due to increased ROS and 
fa
 
4.2.4 Mitochondrial Respiration and Stress Protein Expression 
4.2.4.1 Hsp60 Expression 
As Hsp60 is a mitochondrial stress protein, it would be expected that the expression 
levels may be higher in the treatment group.  However, no statistical difference in 
Hsp60 expression was observed between control and treatment embryos.  In a study 
by Harvey et al. (2007), comparing 2%, 7%, and 20% O2 levels during culture of 
IVP bovine embryos, no difference in Hsp60 expression at mRNA level was reported 
at blastocyst stage.  In this study, at blastocyst stage Hsp60 protein was present but 
due to insufficient immunodetection, statistical analyses were unable to be completed. 
 
4.2.4.2 SOD2 Expression 
SOD2 is an enzyme that functions in defence against oxidative stress and is 
mitochondria specific (O’Brien et al., 2004).  The expression of SOD2 protein at day 
15 was 1.5 times higher in the control group compared to the treatment group.  While 
no studies to date have investigated SOD2 expression at day 15, others have 
conducted research at blastocyst level.  Harvey et al. (1995) failed to see SOD2 
transcription in bovine embryos; however Lequarre et al. (2001) detected SOD2 in 
80% of blastocysts and suggested that culture conditions influenced expression of 
SOD2.  Higher levels of SOD2 mRNA have been reported in in vivo embryos 
compared to IVP embryos, which was suggested to relate to higher (possibly double) 
cell numbers in in vivo embryos (Lequarre et al., 2001).  Due to increased ROS from 
oxidative 
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e higher – resulting in fewer cells (Rizos et al., 2003).  This may explain why the 
 of cellular 
nctions including cell proliferation and differentiation.  COX2 over-expression has 
d TIM is an enzyme involved in 
lycolysis.  There was no statistical difference in expression between control and 
b
control group had significantly higher expression of SOD2 than the treatment group. 
 
4.2.4.3 COX2 Expression 
COX2 converts arachidonic acid to prostaglandin, and is essential for blastocyst 
implantation (Lim et al., 1999).  Prostaglandins participate in a variety
fu
also been associated with malignant cancer phenotypes, which has been linked with 
increased ROS (Pathak et al., 2005).  No statistical differences of COX2 expression 
were present between the control and treatment groups at day 15. 
 
4.2.4.4 TIM Expression 
TIM is a glycolytic enzyme that plays an important role in several metabolic 
pathways and is essential for efficient energy production.  Higher quantities of 
glucose are required during oxidative stress an
g
treatment groups, which suggests that higher amounts of TIM are not transcribed 
during oxidative stress.  No data are presently available on increased or decreased 
expression of TIM during bovine embryonic development.  However, one study 
(Kathiresan et al., 2006) has investigated the expression of TIM during embryonic 
development of crocodiles and found that TIM activity increased with the 
advancement of in vivo embryonic development. 
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.2.4.5 Hsp70 Expression 
enes to be expressed, which facilitates the 
s expressed at mRNA level in day 15 embryos; 
owever no differences were identified between control and treatment sample groups, 
osphate pathways, and consequently GLUT1 transportation of glucose 
opes et al., 2007).  Bovine IVP embryos have been demonstrated to respond to 
 the expression of GLUT1 (Harvey et 
4
Hsp70 is one of the earliest embryonic g
refolding or degradation of damaged proteins (Calabrese et al., 2005), and regulates 
apoptosis and embryonic development (Beere et al., 2000, Saleh et al., 2000).  
Studies have found that Hsp70 is upregulated in embryos generated in culture 
medium that induced cellular stress compared to control (Sagirkaya et al., 2006, 
Wrenzycki et al., 2001).  Hsp70 wa
h
which suggests that the embryos were not under cellular stress in the in vivo 
environment at day 15. 
 
4.2.4.6 GLUT1 expression 
GLUT1 is a facilitative glucose transporter, which is involved in glycolysis and 
belongs to a family of 9 isoforms.  ATP demands correlate with higher respiration 
rates and glucose uptake by embryos, generating an increase in the glycolytic and 
pentose ph
(L
changes in oxygen concentrations by altering
al., 2004).  However, other researchers (Lazzari et al., 2002, Sagirkaya et al., 2006) 
have found no difference in GLUT1 expression between the in vivo control and in 
vitro treatment groups; hence there is debate whether this isoform plays such a crucial 
role in embryonic glucose uptake from the environment as has previously been 
thought.  In this study there was no visible difference of GLUT1 expression between 
treatment and control groups.  
   130
esults of this study indicate that cellular stress proteins are present in cloned 
tal t igh oxygen 
nces were observed between control and treatment 
rowth.  The study by Fischer-Brown et al. (2005) suggests a link between 
e placental abnormalities and their study on calf 
4.3 SUMMARY 
 
R
placen issues and IVP embryo tissue that has been cultured under h
conditions.  Morphological differe
IVP embryos, which may be linked to oxidative stress.  The significant differences 
observed between control and treatment groups in both the cloned investigation and 
the oxidative stress trial need to be explored further, possibly using a different 
quantification measurement, such as analysis with software other than Quantity One, 
e.g., Scion Image software or AlphaEase™ densitometry software.  It has been 
established that mitochondrial stress proteins such as Hsp60 are involved in cellular 
signalling, which may result in altered gene transcription and aberrant embryonic 
g
observational similarities in clon
placental morphology at parturition after embryonic growth in culture medium under 
high oxygen concentration.  Their study implicates oxidative stress and increased 
ROS production, which may induce damaging epigenetic effects that lead to 
abnormal fetal and placental growth.  Based on the evidence from other researchers 
and the results of this study, I would suggest a link between mitochondrial oxidative 
stress and a role in embryonic development, and would encourage further 
investigation in this area. 
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